https://www.dailyhealthindustry.it/pfizer-da-studio-di-fase-3-buoni-risultati-per-marstacimab-emofilia/ 2023-05-31T11:46:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-medtech-patrizio-fatale-nuovo-gm-di-ethicon-italia/ 2023-05-31T10:08:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/samsung-bioepis-ok-ce-a-epysqli-biosimilare-di-eculizumab/ 2023-05-31T11:45:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-investe-200-milioni-di-euro-in-10-anni-in-italia/ 2023-05-31T12:38:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/schillaci-valutiamo-revisione-tetti-spesa-e-di-inserire-nel-fondo-anche-farmaci-a-innovativita-condizionata/ 2023-05-31T13:51:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rappuoli-a-10-anni-dal-vaccino-anti-meningococco-b-sogno-che-la-malattia-sparisca/ 2023-06-01T07:49:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/informazione-medico-scientifica-necessita-di-adattare-il-tipo-di-informazione-al-soggetto-che-la-riceve-intervista-a-cinzia-ortega/ 2023-06-01T09:50:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-arriva-lok-fda-per-vaccino-contro-lrsv/ 2023-06-01T15:28:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-e-il-real-madrid-in-campo-contro-la-malnutrizione/ 2023-06-01T10:25:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nel-2028-i-farmaci-per-il-snc-fattureranno-oltre-10-mld-di-dollari/ 2023-06-01T13:09:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-nasce-la-precision-unit-si-occupera-di-terapie-digitali-nellambito-della-consumer-health/ 2023-06-01T14:01:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/asst-rhodense-propone-a-pazienti-oncologici-vaccinazione-contro-herpes-zoster-in-reparto/ 2023-06-01T14:55:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-seno-in-stadio-iniziale-ribociclib-di-novartis-riduce-significativamente-il-rischio-di-recidiva-del-25/ 2023-06-05T07:55:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-del-polmone-con-osimertinib-l88-dei-pazienti-vivo-a-cinque-anni/ 2023-06-05T07:50:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-la-fiducia-viene-dallest/ 2023-06-05T09:09:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-trasferisce-la-sede-a-basilea/ 2023-06-05T09:26:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-aziende-pharma-primo-settore-per-azioni-di-sostenibilita-ambientale/ 2023-06-05T10:27:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-al-congresso-asco-gli-ultimi-risultati-degli-studi-keynote-671-e-ind-227/ 2023-06-05T12:18:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-sacituzumab-govitecan-migliora-la-sopravvivenza-rispetto-alla-chemioterapia-nel-carcinoma-mammario-metastatico-hr-her2/ 2023-06-05T17:13:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brevetto-unitario-europeo-in-vigore-dal-1-giugno-efpia-bene-ma-prevedere-clausole-di-deroga/ 2023-06-06T07:21:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/j-ottimi-risultati-per-la-terapia-cart-carvykti/ 2023-06-06T15:46:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-da-trastuzumab-deruxtecan-risposte-clinicamente-significative-e-durature-in-pazienti-con-diversi-tumori-solidi-avanzati-her2-positivi/ 2023-06-06T10:21:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/on-line-su-fofi-live-la-prima-puntata-di-health-conversation-la-pcr-in-farmacia-come-e-perche/ 2023-06-06T10:39:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-verso-lacquisizione-di-biocorp/ 2023-06-06T12:29:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eisai-colpita-da-un-attacco-ransomware/ 2023-06-07T09:04:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-e-msd-presentati-allasco-nuovi-dati-sulla-combo-vaccino-mrna-keytruda-nel-melanoma/ 2023-06-07T15:20:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antibiotici-arriva-una-nuova-certificazione-amr/ 2023-06-07T10:29:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/via-libera-della-commissione-ue-al-vaccino-per-il-virus-sinciziale-negli-anziani-gli-esperti-era-atteso-da-tempo/ 2023-06-07T12:34:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novavax-accordo-triennale-con-bill-melinda-gates-medical-research-institute-matrix-m-nella-ricerca-preclinica-sui-vaccini/ 2023-06-07T13:02:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lintelligenza-artificiale-rivoluziona-la-medicina-legale-a-roma-un-convegno-su-rischi-e-benefici/ 2023-06-08T09:38:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-roche-al-via-la-nuova-edizione-del-bando-per-le-associazioni-di-pazienti/ 2023-06-08T09:57:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/catalent-potenzia-la-piattaforma-onebio/ 2023-06-08T10:32:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-agenzie-ue-aggiornare-vaccini-in-vista-della-campagna-autunnale/ 2023-06-08T11:00:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-investira-97-milioni-di-euro-in-2-anni-per-la-rs-realizzando-oltre-200-studi/ 2023-06-08T11:15:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/quanto-e-resiliente-il-biopharma/ 2023-06-08T14:19:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-samsung-biologics-la-produzione-dei-biosimilari-per-conto-di-pfizer/ 2023-06-09T09:26:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ai-nella-ricerca-di-farmaci-contro-il-cancro-in-campo-anche-luniversita-di-sydney/ 2023-06-09T10:00:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/edqm-nel-rapporto-2022-lo-stato-dellarte-della-farmacopea-europea/ 2023-06-09T12:31:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/i-desiderata-del-paziente-visite-in-presenza-e-accesso-alle-cure/ 2023-06-09T13:37:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-ciltacabtagene-autoleucel-riduce-del-74-il-rischio-di-progressione-malattia-o-morte-nel-mm-rispetto-ai-regimi-standard/ 2023-06-09T14:45:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-nuovi-dati-positivi-per-crovalimab-nella-epn/ 2023-06-09T15:26:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ospedale-del-futuro-loms-raccomanda-le-linee-guida-del-politecnico-di-milano/ 2023-06-09T15:54:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valentino-confalone-novartis-dal-forum-in-masseria-al-lavoro-col-governo-per-rendere-il-paese-piu-attrattivo-via-al-progetto-choose-italy/ 2023-06-09T17:36:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/joanne-jervis-al-timone-di-daiichi-sankyo-italia/ 2023-06-12T08:10:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eisaibiogen-lecanemab-vicino-allapprovazione-fda/ 2023-06-12T12:19:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-nuovo-sito-per-la-produzione-di-terapie-cellulari/ 2023-06-12T12:40:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/google-cloud-e-mayo-clinic-collaborazione-per-lai/ 2023-06-12T13:24:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-acquisisce-la-biotech-usa-chinook-per-35-miliardi-di-dollari/ 2023-06-13T08:57:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-oltre-2-miliardi-di-dollari-per-scoprire-farmaci-per-le-malattie-croniche/ 2023-06-13T12:24:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/indagine-cost-of-illness-sullartrite-reumatoide-la-remissione-fa-risparmiare-12-000-euro-lanno-al-paziente/ 2023-06-13T12:25:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giornata-dellinnovazione-farmindustria-alt-a-revisione-legislazione-farmaceutica-europea-che-indebolisce-proprieta-intellettuale/ 2023-06-13T12:33:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-in-sicilia-dibattito-acceso-per-innovare-nella-presa-in-carico/ 2023-06-13T12:45:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-aip-pandemia-finita-ma-non-per-i-fragili-esperti-a-confronto-a-roma/ 2023-06-13T12:50:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-altri-55-milioni-di-euro-per-lo-stabilimento-di-rieti/ 2023-06-13T14:02:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antibiotico-resistenza-approvata-dal-consiglio-europeo-la-nuova-raccomandazione-sulla-resistenza-antimicrobica/ 2023-06-13T15:10:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/per-sbloccare-laumento-del-tetto-della-farmaceutica-diretta-si-attende-decreto-mef-salute/ 2023-06-14T08:28:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/almirall-aumento-di-capitale-da-200-milioni-di-euro/ 2023-06-14T09:44:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-diventa-azienda-certificata-per-luguaglianza-di-genere/ 2023-06-14T09:54:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valneva-vaccino-contro-chikungunya-produce-risposta-immunitaria-del-99-dei-casi/ 2023-06-14T12:52:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dispositivi-medici-nasce-il-gruppo-di-lavoro-di-esperti-sulla-governance/ 2023-06-14T15:39:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/andrea-musilli-nominato-country-manager-oncologia-regeneron-in-italia/ 2023-06-13T13:04:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lefpia-verso-nuove-raccomandazioni-per-migliore-accesso-e-trasparenza-dati-su-pagamenti-a-medici-e-stakeholder-sanitari/ 2023-06-15T10:10:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/egualia-i-produttori-di-principi-attivi-e-farmaci-senza-brevetto-scrivono-a-von-der-leyen-per-carenze-farmaci/ 2023-06-15T12:00:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-punta-forte-sullai/ 2023-06-15T12:32:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gemmato-riforma-aifa-entro-qualche-settimana-e-urso-annuncia-un-piano-industriale-entro-lanno/ 2023-06-15T13:17:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/startup-beacon-raccoglie-120-milioni-di-dollari-per-sviluppare-terapie-geniche-oculari/ 2023-06-15T13:19:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-infettivologi-ruolo-monoclonali-importante-in-terapia-precoce-anziani/ 2023-06-16T07:53:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-piano-di-azione-per-incrementare-luso-dei-biosimilari-a-livello-globale/ 2023-06-16T10:23:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/radiofarmaci-inaugurato-in-germania-il-piu-grande-sito-al-mondo-per-la-produzione-di-lutezio177/ 2023-06-16T12:37:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-e-verve-therapeutics-partnership-per-programma-di-editing-genetico/ 2023-06-16T13:17:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-al-polmone-da-janssen-nuovi-dati-sul-trattamento-dei-pazienti-con-mutazioni-dellegfr-con-la-combinazione-di-amivantamab-e-lazertinib/ 2023-06-16T14:01:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanitalk-5-letica-della-digitalizzazione-per-non-tradire-il-diritto-alla-salute/ 2023-06-16T14:39:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-ok-aifa-a-rimborsabilita-di-azacitidina-orale-lma/ 2023-06-19T10:33:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/omeoimprese-silvia-nencioni-e-la-nuova-presidente/ 2023-06-19T12:31:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-via-libera-fda-allanticorpo-bispecifico-columvi-nel-dlbcl/ 2023-06-19T12:58:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-antinfluenzale-universale-arriva-un-nuovo-candidato/ 2023-06-19T13:17:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/premio-internazionale-fair-play-menarini-ecco-premiati-della-xxvii-edizione/ 2023-06-19T15:36:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/small-molecule-un-futuro-fiorente-nella-cdmo/ 2023-06-20T09:12:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/osteoporosi-arriva-una-pillola-robotica-per-la-somministrazione-dei-farmaci/ 2023-06-20T09:44:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-europa-e-youtube-per-la-qualita-delle-informazioni-sanitarie-online/ 2023-06-20T12:18:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cannes-lions-2023-assegnati-i-primi-grand-prix/ 2023-06-20T12:58:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellece-awards-2023-i-vincitori-della-quinta-edizione/ 2023-06-21T12:28:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-contro-virus-respiratorio-sinciziale-rsv-negli-anziani-protezione-prolungata-per-due-stagioni/ 2023-06-21T09:06:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-acquisisce-dice-therapeutics/ 2023-06-21T09:43:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-cellulari-e-geniche-e-lora-delle-startup/ 2023-06-21T12:46:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumori-la-fda-lancia-programma-pilota-per-monitorare-uso-test-diagnostici-biomarker-in-abbinamento-a-cure/ 2023-06-21T13:19:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-a-parma-airevolution-2023-esperti-a-confronto-sulle-nuove-armi-terapeutiche-per-le-patologie-respiratorie/ 2023-06-22T07:37:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-oncology-9-nuovi-farmaci-approvati-nel-mondo-in-10-anni/ 2023-06-22T10:22:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aiom-gli-oncologi-convocati-da-aifa-costretti-alle-dimissioni-mai-riunito-il-gruppo-di-lavoro-siano-condivise-le-decisioni/ 2023-06-22T11:01:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bavarian-nordic-buoni-dati-di-efficacia-per-il-vaccino-contro-chikungunya/ 2023-06-22T12:41:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-via-libera-a-empagliflozin-per-la-cura-del-diabete-in-eta-pediatrica/ 2023-06-23T06:41:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sperimentazioni-cliniche-in-ue-ema-al-via-nuova-piattaforma-multi-stakeholder-per-migliorarle/ 2023-06-22T13:43:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/efpia-rinnova-gruppo-di-presidenza-e-lancia-5-proposte-per-modificare-la-proposta-di-legislazione-europea/ 2023-06-23T12:45:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/con-iter-semplificato-aifa-per-negoziazione-generici-32-procedure-presentate-nel-2022-rispetto-al-2020/ 2023-06-23T13:36:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-da-aifa-ok-per-rimborsabilita-di-maribavir-infezione-malattia-da-citomegalovirus/ 2023-06-26T16:28:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gpp-nasce-coalizione-tra-pazienti-professionisti-societa-scientifiche-aziende-e-istituzioni-per-accendere-i-riflettori-malattia-sulla-patologia/ 2023-06-26T12:33:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cefalea-primaria-cronica-a-camerae-sanitatis-le-riflessioni-sullultimo-miglio-per-la-presa-in-carico-della-patologia/ 2023-06-26T13:04:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-inizia-la-week-of-possibilities-200-volontari-in-italia-sostengono-le-comunita-locali/ 2023-06-26T16:36:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ok-fda-alla-prima-terapia-genica-per-la-distrofia-muscolare-di-duchenne-il-prezzo-32-mln-di-dollari/ 2023-06-26T13:55:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-al-via-vacciconcura-campagna-di-sensibilizzazione-per-viaggiare-in-sicurezza/ 2023-06-26T14:18:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lundbeck-dal-1-ottobre-charl-van-zyl-nuovo-ceo/ 2023-06-27T09:45:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-luhcr-premia-lo-stabilimento-di-ascoli-piceno-per-la-politica-a-favore-dei-rifugiati/ 2023-06-27T10:11:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-chmp-raccomanda-soliris-nella-miastenia-grave-generalizzata-refrattaria/ 2023-06-27T12:17:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-tik-tok-piacciono-medici-e-infermieri/ 2023-06-27T12:44:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-ok-chmp-a-trifluridina-tipiracil-e-bevacizumab-nel-carcinoma-colorettale-metastatico/ 2023-06-27T13:20:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/galapagos-biopharma-italy-stefania-bassanini-nominata-senior-medical-director/ 2023-06-27T14:37:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-chmp-raccomanda-daprodustat-per-lanemia-nella-ckd/ 2023-06-28T09:31:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-e-vertex-collaborazione-per-la-produzione-di-terapie-cellulari-per-il-diabete/ 2023-06-28T09:53:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anche-eli-lilly-nella-corsa-al-farmaco-per-lobesita-retatrutide-centra-gli-obiettivi-di-fase-ii/ 2023-06-28T12:30:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/advanz-pharma-sceglie-veeva-systems-per-le-operazioni-digitali-in-europa/ 2023-06-28T13:01:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sobi-una-campagna-per-dare-voce-alla-epn-attraverso-lintelligenza-artificiale/ 2023-06-28T13:50:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/herpes-zoster-serve-implementare-la-vaccinazione-nel-paziente-oncologico/ 2023-07-02T15:24:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mrd-in-oncoematologia-limportanza-del-monitoraggio-nel-management-clinico/ 2023-06-29T10:25:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanitalk6-tutti-i-limiti-del-dm77-bello-e-impossibile/ 2023-07-03T08:49:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-tumore-del-fegato-con-regime-stride-1-paziente-su-4-vivo-dopo-quattro-anni/ 2023-06-30T10:21:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/al-via-fase-ii-di-sperimentazione-del-primo-farmaco-small-molecule-generato-dallai/ 2023-06-30T12:25:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-diabetes-care-italy-massimo-balestri-nuovo-gm/ 2023-07-03T09:48:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fujifilm-sceglie-lars-petersen-come-nuovo-ceo-e-presidente/ 2023-07-03T12:35:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-cede-xidra-e-altri-prodotti-oftalmici-a-bausch-lomb/ 2023-07-03T13:10:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ai-quello-che-i-medici-dicono/ 2023-07-03T14:05:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-con-la-sanita-pubblica-per-un-cambio-di-paradigma-nella-prevenzione-dellrsv-nei-bambini-nel-primo-anno-di-vita/ 2023-07-03T15:52:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-campo-estivo-della-smagliante-ada-nella-sede-della-juventus/ 2023-07-04T09:56:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biomed-x-e-sanofi-insieme-per-lo-sviluppo-di-farmaci-guidati-dallai/ 2023-07-04T12:28:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tecnologie-analitiche-di-processo-mercato-in-crescita-nel-settore-farmaceutico/ 2023-07-04T12:53:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-continua-lo-shopping-acquisite-emergence-e-sigilon/ 2023-07-04T13:32:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-risultati-promettenti-per-un-candidato-alla-terapia-della-psoriasi-a-placche/ 2023-07-05T09:53:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/immunoterapie-2022-anno-record-per-le-approvazioni/ 2023-07-05T12:43:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-da-ecdc-protocollo-di-studio-per-verificare-lefficacia-protettiva-dei-vaccini/ 2023-07-05T12:54:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/18-milioni-di-dosi-del-primo-vaccino-contro-la-malaria-a-12-paesi-africani-per-il-periodo-2023-2025/ 2023-07-05T15:49:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dompe-farmaceutici-nuovo-posizionamento-globale/ 2023-07-05T16:17:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-la-farmaceutica-e-il-2-del-pil-ma-senza-stop-al-payback-ai-tetti-di-spesa-e-nuovo-regolamento-ue-il-comparto-rischia-di-perdere-innovazione-e-investimenti/ 2023-07-06T15:52:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/schillaci-innovazione-va-portata-subito-a-pazienti-da-nord-a-sud-riforma-aifa-entro-o-subito-dopo-lestate/ 2023-07-06T14:26:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/wittum-astrazeneca-italia-ci-aspetta-ondata-innovazione-serve-finanziamento-adeguato/ 2023-07-06T16:54:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/luppi-msd-la-nostra-industria-valore-per-il-paese-obiettivi-sfidanti-per-il-futuro-di-crescita/ 2023-07-06T16:58:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mele-lundbeck-italia-il-pharma-locomotiva-da-supportare-per-il-futuro-dellitalia/ 2023-07-06T17:06:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scaccabarozzi-unindustria-esplosi-produzione-ed-export-pharma-e-asset-di-sicurezza-nazionale/ 2023-07-06T17:10:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-commissione-ue-e-hma-al-via-eliminazione-delle-flessibilita-normative-straordinarie-concesse-durante-la-pandemia/ 2023-07-07T08:34:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alessandro-chiesi-nuovo-presidente-del-gruppo-chiesi/ 2023-07-07T09:13:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alzheimer-da-fda-approvazione-piena-a-leqembi-eisaibiogen/ 2023-07-07T09:29:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bausch-lomb-acquisisce-da-jj-la-linea-di-prodotti-oftalmologici-blink/ 2023-07-07T09:51:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anche-apple-nel-metaverso/ 2023-07-07T12:39:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-mercato-delle-organizzazioni-di-ricerca-clinica-e-in-forte-espansione/ 2023-07-07T12:40:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-nuovi-dati-dello-studio-firefish-rafforzano-efficacia-risdiplam-nei-bambini-affetti-da-sma-di-tipo-1/ 2023-07-10T10:46:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novavax-da-ue-si-allimmissione-in-commercio-di-nuvaxovid-covid-19/ 2023-07-10T12:44:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nellarena-dellrsv-entra-anche-moderna/ 2023-07-10T13:08:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sarepta-cede-voucher-revisione-pioritaria-della-terapia-genica-contro-la-malattia-di-duchenne/ 2023-07-10T16:09:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gli-esperti-nel-nuovo-piano-vaccinale-fragilita-tema-centrale-partire-da-ospedale-per-vaccinare-contro-herpes-zoster/ 2023-07-11T08:38:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-ce-a-glofitamab-per-i-linfomi-diffusi-a-grandi-cellule-recidivanti-o-refrattari/ 2023-07-11T09:25:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-geniche-per-locchio-accordo-astellas-4dmt/ 2023-07-11T12:27:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/samsung-biologics-produrra-farmaci-per-novartis/ 2023-07-11T12:55:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-contenenti-semaglutide-e-liraglutide-sotto-la-lente-ema-a-seguito-di-segnalazioni-di-pensieri-suicidi/ 2023-07-11T13:06:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/indagine-italia-longeva-tra-il-2011-e-il-2021-aumentati-dal-26-al-40-gli-italiani-in-condizioni-di-fragilita-lieve-moderata-o-severa/ 2023-07-12T08:13:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-nel-lazio-si-scommette-sul-digitale-per-rendere-coesa-la-presa-in-carico-tra-ospedale-e-territorio/ 2023-07-12T09:29:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-oncologici-phrma-fondamentale-la-ricerca-post-approvazione-per-nuove-applicazioni/ 2023-07-12T12:47:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ibsa-acquisisce-marckyrl-pharma-gmbh-nasce-ibsa-germany/ 2023-07-13T07:19:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-fedele-asl-lecce-ora-momento-giusto-per-anti-zoster-in-vista-autunno-al-via-campagna-con-open-day/ 2023-07-13T08:52:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-in-lombardia-lultimo-miglio-parla-di-liberta-terapeutica-e-digitalizzazione/ 2023-07-13T15:03:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-sponsor-olimpico-usa-fino-a-lo-angeles-2028/ 2023-07-13T09:44:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/porpora-trombotica-trombocitopenica-presentata-interrogazione-parlamentare-per-monitorare-lapplicazione-delle-linee-guida-2021/ 2023-07-13T11:06:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brand-valuation-jj-ancora-in-testa/ 2023-07-13T12:43:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tariffe-ema-parlamento-ue-approva-proposta-di-regolamento-che-mira-ad-aggiornare-il-sistema-delle-fee/ 2023-07-13T14:10:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-via-libera-ce-a-mavacamten-nella-cardiomiopatia-ipertrofica-ostruttiva/ 2023-07-13T14:13:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ocrelizumab-per-iniezione-sottocutanea-non-inferiore-alla-somministrazione-endovenosa-nella-sm/ 2023-07-14T09:35:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-fda-approva-la-prima-pillola-anticoncezionale-senza-prescrizione-medica/ 2023-07-14T10:18:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-basati-su-ai-anche-linstitute-of-cancer-research-di-londra-in-campo/ 2023-07-14T12:32:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/e-arrivato-threads-concorrente-di-twitter-nuova-arma-per-il-marketing-sanitario/ 2023-07-14T13:26:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-da-aifa-via-libera-a-rimborsabilita-di-rinvoq-nella-colite-ulcerosa/ 2023-07-17T09:15:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-non-si-ferma-acquisita-anche-versanis/ 2023-07-17T09:42:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-campagna-di-awareness-sulla-colite-ulcerosa-in-occasione-dei-mondiali-di-calcio-femminile/ 2023-07-17T12:38:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/carenza-di-antibiotici-ue-monitoraggio-domanda-offerta-e-aumento-produzione-in-vista-dellinverno/ 2023-07-17T12:43:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-collaborazione-con-ksq-therapeutics-per-sviluppare-un-inibitore-dellenzima-usp1/ 2023-07-17T13:08:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-italia-alessandra-dorigo-al-timone-delloncologia/ 2023-07-18T09:35:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-astrazeneca-ok-fda-a-beyfortus-nei-neonati-con-rsv/ 2023-07-18T09:57:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotecnologie-rapporto-enea-assobiotec-oltre-13-miliardi-di-fatturato-larea-della-salute-mantiene-il-primato/ 2023-07-18T12:39:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-scommette-sui-farmaci-sirna-acquisita-dtx-pharma/ 2023-07-18T15:26:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-accordo-con-startup-usa-per-sviluppare-10-candidati-farmaci/ 2023-07-19T09:26:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-nasce-larea-dellimmuno-diabetologia/ 2023-07-19T09:55:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-nuovo-buyback-entro-il-2025/ 2023-07-19T12:38:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ministero-della-salute-francesco-vaia-e-il-nuovo-direttore-generale-prevenzione/ 2023-07-19T14:58:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-ok-aifa-a-rimborsabilita-natalizumab-in-nuova-soluzione-per-uso-sottocutaneo/ 2023-07-20T09:09:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trattamento-contro-miastenia-grave-generalizzata-riceve-via-libera-rimborsabilita-da-aifa/ 2023-07-20T09:52:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antivirali-contro-covid-19-i-dati-aifa-ripresi-su-the-lancet-palu-esempio-di-come-attivita-dellagenzia-non-siano-solo-regolatorie/ 2023-07-20T11:34:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuova-riunione-tavolo-pharma-e-biomedicale-al-mimit/ 2023-07-20T13:08:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaceutica-nel-2022-la-spesa-pubblica-oltre-i-20-miliardi/ 2023-07-21T09:08:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-amplia-il-raggio-dazione-del-programma-open-per-valutazioni-celeri/ 2023-07-21T09:17:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanitalk7-salute-di-genere-un-obiettivo-ancora-lontano-ma-sotto-i-riflettori/ 2023-07-21T09:19:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-un-nuovo-impianto-per-vincere-la-sfida-dei-biosimilari/ 2023-07-21T09:44:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/logista-entra-nella-distribuzione-farmaceutica/ 2023-07-21T14:30:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pubblicita-di-farmaci-otc-e-sop-anche-sui-social-network-il-ministero-della-salute-pubblica-nuove-linee-guida/ 2023-07-21T11:58:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-riceve-parere-positivo-chmp-per-trattamento-carcinoma-mammario-avanzato-er-her2-con-mutazione-esr1/ 2023-07-21T14:32:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ok-aifa-a-rimborsabilita-xeljanz-nella-spondilite-anchilosante/ 2023-07-21T16:16:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-via-alla-consultazione-pubblica-sullintelligenza-artificiale-nel-mondo-pharma/ 2023-07-24T10:07:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-da-ema-raccomandazione-per-vaccino-rsv-negli-anziani-e-nelle-donne-in-gravidanza/ 2023-07-24T12:39:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-accordo-con-biotech-usa-per-ricerca-e-sviluppo-inibitori-stat6/ 2023-07-24T13:09:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-lancia-in-uk-il-dispositivo-goresp-digihaler-per-asma-e-bpco/ 2023-07-24T13:53:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bavarian-nordic-interrompe-lo-sviluppo-del-vaccino-contro-lrsv/ 2023-07-25T09:24:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-accordo-con-alnylam-pharmaceuticals-per-lantipertensivo-zilebesiran/ 2023-07-25T09:44:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tetto-spesa-farmaceutica-diretta-in-gu-decreto-salute-mef-che-lo-ridefinisce-per-le-aziende-adempienti-pay-back/ 2023-07-25T09:54:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rsv-chi-vincera-la-corsa/ 2023-07-25T12:58:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/emergenze-sanitarie-ema-pubblica-lista-di-azioni-per-trial-clinici-rapidi-e-di-alta-qualita/ 2023-07-25T13:42:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/grunenthal-presentati-lannual-e-il-responsibility-report/ 2023-07-25T14:12:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-acquisti-diretti-ssn-e-quota-a-carico-dei-cittadini-fanno-volare-la-spesa-la-nuova-analisi-aifa/ 2023-07-26T08:54:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spasticita-post-ictus-la-riabilitazione-non-e-accessoria-ma-un-tassello-essenziale-del-percorso-di-cura-il-punto-a-camerae-sanitatis/ 2023-07-26T09:16:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viiv-healthcare-parere-positivo-chmp-per-cabotegravir-nella-prep/ 2023-07-26T10:22:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/innovazioni-in-sanita-digitale-arriva-il-premio-agenas-sics/ 2023-07-26T20:36:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-aggiorna-la-lista-dei-farmaci-essenziali-in-totale-sono-502-per-gli-adulti-e-361-per-i-bambini/ 2023-07-26T16:18:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-un-2022-allinsegna-della-sostenibilita/ 2023-07-28T08:43:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/confindustria-dm-bene-governo-su-rinvio-payback/ 2023-07-27T12:18:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-e-boehringer-ingelheim-ok-ce-a-jardiance-nella-malattia-renale-cronica/ 2023-07-27T12:40:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-eosinofile-mepolizumab-unica-terapia-di-precisione/ 2023-07-27T16:52:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alexion-astrazeneca-ok-ce-a-eculizumab-nella-miastenia-grave-generalizzata-di-bambini-e-adolescenti/ 2023-07-28T09:21:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/le-tecnologie-digitali-migliorano-le-performance-degli-operatori-sanitari-lo-studio-oms-europa/ 2023-07-28T09:35:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/modernamsd-parte-fase-iii-studio-combo-vaccinokeytruda-nel-melanoma/ 2023-07-30T10:23:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-biomedica-e-farmacologica-mimit-approva-tre-accordi-per-linnovazione-fondi-per-23-mln-euro/ 2023-07-28T10:21:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amr-oms-uso-piu-esteso-di-vaccinazioni-gia-esistenti-potrebbe-salvare-mezzo-milione-di-vite-lanno/ 2023-07-31T13:17:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/studio-apre-allimmunoterapia-contro-la-sla/ 2023-08-01T13:52:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/verso-nuovi-antibiotici-classe-di-molecole-inibisce-meccanismi-di-protezione-dei-batteri/ 2023-08-01T13:54:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuove-molecole-combattono-diversi-virus-facendo-scoppiare-le-loro-membrane-protettive/ 2023-08-04T10:30:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-fatturato-a-12-nel-primo-semestre-rispetto-allanno-precedente/ 2023-08-04T11:57:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-verso-una-nuova-gestione-dellepilessia-come-priorita-di-salute-pubblica/ 2023-08-28T09:11:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ok-ce-ad-abrysvo-nel-rsv-in-neonati-e-anziani/ 2023-08-28T09:34:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-mese-di-agosto-doro-per-wegovy/ 2023-08-28T12:27:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-herpes-zoster-nuovi-dati-gsk-dimostrano-lefficacia-al-100-nella-prevenzione-dellinfezione-in-adulti-di-eta-pari-o-superiore-a-50-anni-in-cina/ 2023-08-28T15:59:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipercolesterolemia-con-acido-bempedoico-20-rischio-di-eventi-cardiovascolari-gravi-nei-pazienti-ad-alto-rischio/ 2023-08-28T14:43:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fibrillazione-atriale-trattamento-con-edoxaban-a-4-anni-riduce-rischio-morte-per-tutte-le-cause/ 2023-08-28T14:45:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nestle-health-science-un-super-manager-di-meta-a-capo-del-marketing-usa/ 2023-08-29T09:06:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/stada-crescita-a-due-cifre-nel-primo-semestre-2023/ 2023-08-29T10:08:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-primi-dati-positivi-per-terapia-cellulare-per-il-parkinson/ 2023-08-29T10:42:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-farxiga-guida-la-pipeline-cardiovascolare/ 2023-08-29T13:04:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-presenta-a-fda-ed-ema-la-domanda-di-approvazione-per-skyrizi-nella-colite-ulcerosa/ 2023-08-30T09:27:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-accordo-con-cellares-per-produzione-automatizzata-di-terapia-car-t/ 2023-08-30T09:56:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-ce-a-estensione-risdiplam-ai-neonati-con-sma/ 2023-08-30T14:03:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-covid-ema-raccomanda-approvazione-vaccino-cominarty-aggiornato-a-variante-kraken/ 2023-08-30T13:30:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-ancora-shopping-nellarea-obesita-acquisita-la-start-up-embark-biotech/ 2023-08-31T12:11:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-ok-ce-per-keytruda-come-terapia-di-prima-linea-per-il-cancro-gastrico/ 2023-08-31T12:34:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-lotta-al-fumo-e-riduzione-del-rischio/ 2023-08-31T16:05:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dalla-fda-una-guida-per-luso-dei-dati-real-world/ 2023-09-01T09:31:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-nuove-nomine-nellexecutive-committee/ 2023-09-01T09:54:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-ok-fda-a-estensione-reblozyl-alle-sindromi-mielodisplastiche/ 2023-09-01T13:09:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/italia-tornano-ad-aumentare-i-casi-di-covid/ 2023-09-01T15:16:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-italia-jorge-l-lopez-nuovo-general-manager-dello-stabilimento-produttivo-di-latina/ 2023-09-07T12:19:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-via-libera-allacquisizione-di-horizon-therapeutics/ 2023-09-04T10:21:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-una-corsa-ciclistica-per-battere-il-cancro/ 2023-09-04T12:45:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-nuovi-dati-su-alecensa-nel-tumore-al-polmone-con-mutazione-alk/ 2023-09-04T13:35:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattia-di-crohn-mercato-in-evoluzione/ 2023-09-04T14:22:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-innovazione-e-integrazione-accesso-a-cure-e-metodi-innovativi-di-presa-in-carico-dei-pazienti-con-cefalea-primaria-cronica/ 2023-09-04T15:30:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaceutica-da-cernobbio-le-linee-per-il-futuro-del-settore-in-italia-serve-una-nuova-governance-del-farmaco/ 2023-09-04T16:10:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-da-oggi-in-italia-nuova-indicazione-per-kymriah-rimborsata-dal-ssn/ 2023-09-05T09:40:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-il-nice-raccomanda-elfabri-per-la-malattia-di-fabry/ 2023-09-05T09:45:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/clima-efpia-aziende-del-farmaco-pronte-a-sfide-ambiziose-libro-bianco-con-tutti-i-progetti/ 2023-09-05T12:36:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-investe-negli-impianti-di-produzione-dei-vaccini/ 2023-09-05T12:35:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/italfarmaco-ema-accetta-domanda-farmaco-per-la-terapia-della-malattia-di-duchenne/ 2023-09-06T09:17:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/illumina-il-nuovo-ceo-e-jacob-thaysen/ 2023-09-06T17:10:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-arriva-negli-usa-elrexfio-anticorpo-bispecifico-potenziale-blockbuster/ 2023-09-06T12:35:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-oncologiche-a-base-di-mrna-un-mercato-da-2-mld-di-dollari-entro-il-2029/ 2023-09-06T13:15:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alice-zilioli-nuovo-direttore-marketing-di-roche-diabetes-care-italy/ 2023-09-06T13:29:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-il-tavolo-di-revisione-della-governance-farmaceutica-al-ministero-della-salute/ 2023-09-06T13:38:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-moderna-da-vaccino-aggiornato-forte-risposta-immunitaria-contro-la-nuova-variante-pirola/ 2023-09-06T13:41:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/landazabal-gsk-serve-un-piano-marshall-per-le-scienze-della-vita/ 2023-09-06T14:01:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-da-aifa-rimborsabilita-per-atezolizumab-in-adiuvante-nel-trattamento-del-tumore-al-polmone-non-a-piccole-cellule-in-fase-iniziale/ 2023-09-06T15:56:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-italia-riccardo-samele-e-il-nuovo-market-access-director/ 2023-09-07T09:08:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-affida-a-jane-grogan-la-direzione-della-ricerca/ 2023-09-07T09:36:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/crisi-climatica-chiesi-un-report-con-leconomist-impact-sulla-qualita-dellaria-le-preoccupazioni-degli-europei/ 2023-09-07T10:37:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-via-libera-in-europa-a-talquetamab-nel-mieloma-multiplo-recidivante-e-refrattario/ 2023-09-07T12:20:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-nuovi-dati-su-mavacamten-confermano-una-risposta-costante-e-duratura-nei-pazienti-con-cardiomiopatia-ipertrofica-ostruttiva/ 2023-09-07T13:38:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nmosd-inebilizumab-terapia-costo-efficace/ 2023-09-07T14:22:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-obiettivo-carbon-negative-entro-il-2030/ 2023-09-08T09:36:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-patrick-horber-e-il-nuovo-presidente-internazionale/ 2023-09-08T09:55:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-regno-unito-rientra-nellaccordo-horizon-europe/ 2023-09-08T15:04:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medici-e-informatori-scientifici-entra-in-campo-lia/ 2023-09-08T13:01:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-affrontare-la-spasticita-post-ictus-percorsi-di-cura-e-accesso-alla-riabilitazione/ 2023-09-11T11:11:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/accordo-alexion-astrazeneca-e-verge-genomics-per-ricerca-malattie-sistema-nervoso-con-ia/ 2023-09-11T15:04:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/premio-early-bioneers-per-giovani-ricercatori-e-startup-prorogato-al-29-settembre-il-termine-per-inviare-le-candidature/ 2023-09-11T12:43:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/virus-ebola-ce-approva-estensione-delle-indicazioni-del-vaccino-di-msd/ 2023-09-11T12:58:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-il-nice-raccomanda-mounjaro-di-eli-lilly/ 2023-09-11T13:25:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-fda-approva-i-booster-aggiornati-di-pfizer-e-moderna/ 2023-09-12T08:31:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-accordo-con-samsung-bioepis-per-commercializzare-il-biosimilare-di-stelara-jassen/ 2023-09-12T08:54:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otsuka-punta-su-shape-per-progettare-terapie-geniche-per-malattie-dellocchio/ 2023-09-12T09:18:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/riforma-aifa-dalla-nuova-mission-al-dialogo-con-gli-stakeholder-dal-think-thank-ithaca-un-documento-con-i-10-temi-da-affrontare/ 2023-09-12T10:36:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-aifa-approva-rimborsabilita-trastuzumab-deruxtecan-nel-carcinoma-mammario-her2-positivo-non-resecabile-o-metastatico/ 2023-09-12T15:55:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-si-apre-al-dialogo-con-gli-stakeholder-al-via-aifa-incontra-incontri-in-trasparenza-con-aziende-societa-scientifiche-associazioni-pazienti/ 2023-09-13T06:29:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eisai-un-ecosistema-digitale-per-le-malattie-neurodegenerative/ 2023-09-13T08:53:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-nsclc-buoni-risultati-per-trodelvy-in-combo-con-keytruda-msd/ 2023-09-13T09:44:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-al-seno-torna-il-cardiobreast-dragon-boat-festival/ 2023-09-14T06:15:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/intelligenza-artificiale-big-bang-nel-2030/ 2023-09-14T05:48:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jpm-novo-nordisk-ed-eli-lilly-regine-del-mercato-dellobesita/ 2023-09-14T08:34:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-roadmap-a-tappe-serrate-per-il-2028/ 2023-09-14T09:24:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pmi-farmaceutiche-europee-le-proposte-della-ce/ 2023-09-14T13:06:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-ok-aifa-a-rimborsabilita-skyrizi-nella-malattia-di-crohn-da-moderata-a-severa/ 2023-09-14T13:26:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ifpma-lavorare-subito-insieme-per-vaccini-e-terapie-veloci-contro-nuove-pandemie/ 2023-09-14T13:31:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-combo-osimertinib-chemioterapia-prolunga-la-sopravvivenza-nel-tumore-del-polmone-avanzato-con-mutazione-di-egfr/ 2023-09-14T15:22:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-rinnova-la-visual-identity/ 2023-09-14T15:44:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-da-ema-via-libera-anche-al-vaccino-aggiornato-di-moderna/ 2023-09-14T16:01:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-investe-nel-gas-naturale-rinnovabile-per-i-propri-impianti/ 2023-09-15T09:42:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nsclc-nuove-speranze-dal-vaccino-della-biotech-francese-ose-immunotherapeutics/ 2023-09-15T10:11:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-pubblica-from-the-margins-un-libro-innovativo-sui-percorsi-dei-pazienti/ 2023-09-15T15:04:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-arrivano-le-direttive-del-ministero-della-salute-su-obiettivi-da-perseguire/ 2023-09-15T13:05:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-olipudasi-alfa-migliora-la-funzione-polmonare-negli-adulti-con-asmd/ 2023-09-15T13:51:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-via-libera-aifa-a-lunsumio-nel-linfoma-follicolare-recidivante-o-refrattario/ 2023-09-18T09:41:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapia-del-dolore-al-primo-farma-talk-di-fofi-live-farmacisti-mmg-e-specialisti-a-confronto-per-una-nuova-idea-di-equipe-multidisciplinare/ 2023-09-18T15:20:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-1-miliardo-di-euro-per-nuovo-impianto-in-irlanda/ 2023-09-18T12:37:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/monitoraggio-remoto-dei-pazienti-mercato-sempre-piu-ricco/ 2023-09-18T13:06:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-nuova-indicazione-per-botox/ 2023-09-19T08:32:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-sfoltisce-il-portafoglio-e-cede-11-prodotti-per-il-snc/ 2023-09-19T09:15:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/colite-ulcerosa-un-policy-brief-per-la-presa-in-cura-globale-del-paziente/ 2023-09-19T10:33:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-ministro-schillaci-allassemblea-generale-dellonu/ 2023-09-19T14:17:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-restituisce-a-beigene-i-diritti-sullinibitore-pd1-tislelizumab/ 2023-09-20T08:05:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biontech-e-cepi-insieme-per-sviluppare-vaccino-a-mrna-contro-il-vaiolo-delle-scimmie/ 2023-09-20T08:33:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/capitalizzazione-di-mercato-pharma-in-crescita-nel-q2/ 2023-09-20T09:21:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-accordo-con-aspen-per-insulina-nellafrica-subsahariana/ 2023-09-20T09:58:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viiv-healthcare-via-libera-ce-ad-apretude-farmaco-a-lunga-durata-dazione-per-la-prep/ 2023-09-20T12:57:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-ce-approva-orserdu-serd-orale-per-il-trattamento-del-cancro-della-mammella/ 2023-09-20T15:54:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-spesa-farmaceutica-e-sottofinanziata-ora-servono-meno-burocrazia-revisione-tetti-di-spesa-e-freno-allinsostenibile-payback-intervista-a-cattani-farmindustria/ 2023-09-21T07:36:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assemblea-generale-onu-schillaci-rafforzare-cooperazione-internazionale-per-migliorare-la-salute-globale/ 2023-09-21T09:02:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genentech-roche-partnership-con-peptidream-per-sviluppare-radiofarmaci/ 2023-09-21T09:28:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-revisione-prioritaria-combo-keytruda-chemioradioterapia-per-la-terapia-del-cancro-della-cervice-uterina-i-n-fase-iniziale/ 2023-09-21T13:48:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/da-alfasigma-200-mila-euro-alla-protezione-civile-dellemilia-romagna-per-le-popolazioni-colpite-dallalluvione/ 2023-09-21T12:19:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/adf-walter-farris-confermato-alla-presidenza/ 2023-09-22T09:03:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-novo-nordisk-136-milioni-di-dollari-per-un-hub-di-produzione-di-terapie-cellulari/ 2023-09-22T09:00:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otsuka-e-astex-ok-ce-a-combo-decitabina-e-cedazuridina-negli-adulti-affetti-da-lma/ 2023-09-22T09:41:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nih-via-alla-sperimentazione-per-il-vaccino-universale-contro-linfluenza/ 2023-09-22T12:34:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-italia-nuove-nomine-a-capo-di-due-bu/ 2023-09-25T08:54:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nice-raccomanda-mirikizumab-di-eli-lilly-per-la-colite-ulcerosa/ 2023-09-25T09:35:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/confindustria-dm-e-fifo-lavoriamo-per-cancellare-il-payback/ 2023-09-25T10:34:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gedeon-richter-italia-due-appuntamenti-radio-per-parlare-di-contraccezione-femminile/ 2023-09-25T11:19:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spesa-farmaceutica-nei-primi-5-mesi-del-2023-spesa-supera-i-9-mld/ 2023-09-27T09:27:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/riforma-della-legislazione-farmaceutica-in-ue-kyriakides-obiettivo-bilanciamento-fra-necessita-pazienti-e-industria/ 2023-09-26T08:36:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/beigene-ce-approva-tislelizumab-come-monoterapia-per-il-cancro-esofageo-dopo-chemioterapia/ 2023-09-26T08:47:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-giornata-mondiale-per-il-cuore-87-pazienti-ipertesi-a-rischio-cv-elevato/ 2023-09-26T12:34:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-acquisisce-intercept-pharmaceuticals/ 2023-09-27T09:28:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-aifa-approva-vaccino-contro-la-dengue/ 2023-09-27T08:38:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-sandoz-il-4-ottobre-lo-spin-off/ 2023-09-27T09:03:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-ed-evotec-partnership-per-le-malattie-cardiometaboliche/ 2023-09-27T09:39:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bpco-una-corsa-ciclistica-per-conoscerla-e-combatterla/ 2023-09-27T15:42:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/con-la-manovra-e-arrivato-il-momento-di-cancellare-il-payback-sarebbe-scelta-politicamente-vantaggiosa-per-il-governo-intervista-a-boggetti-confindustria-dm/ 2023-09-27T13:20:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-accordo-con-ionis-pharmaceuticals-per-due-candidati-rna-per-alzheimer-e-huntington/ 2023-09-28T08:57:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-ce-approva-il-primo-biosimilare-in-europa-per-la-sclerosi-multipla/ 2023-09-28T09:44:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/produzione-farmaceutica-efpia-con-i-nuovi-divieti-su-pfas-a-rischio-600-prodotti-essenziali/ 2023-09-28T10:22:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-e-fimmg-firmato-protocollo-di-intesa-su-ricerca-clinica/ 2023-09-28T10:50:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/egualia-con-la-manovra-si-dia-respiro-alle-aziende-dei-farmaci-equivalenti/ 2023-09-29T08:16:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-ok-fda-a-somministrazione-sottocutanea-di-entyvio-nella-colite-ulcerosa/ 2023-09-29T09:12:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bluebird-bio-accordo-con-lonza-per-aumentare-la-produzione-delle-terapie-geniche/ 2023-09-29T14:29:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jazz-pharmaceuticals-via-libera-ce-a-enrylaze-come-componente-di-un-regime-chemioterapico-multi-agente-per-il-trattamento-della-lla-e-del-lbl-in-pazienti-adulti-e-pediatrici/ 2023-09-29T13:33:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/christine-fox-a-capo-di-teva-usa/ 2023-10-02T15:11:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nobel-medicina-2023-a-katalin-kariko-e-drew-weissman-per-scoperte-vaccini-a-mrna/ 2023-10-02T15:04:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anna-maria-bencini-nuova-general-manager-di-takeda-italia/ 2023-10-02T10:32:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/al-via-janssen-patient-association-lab-per-un-ecosistema-salute-piu-inclusivo/ 2023-10-02T14:42:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viatris-cede-tre-bu-operazione-da-52-miliardi-di-dollari/ 2023-10-03T08:34:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-chiude-la-digital-health-ed-esce-dallalleanza-con-apple/ 2023-10-03T09:09:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-fda-approva-antidepressivo-first-in-class/ 2023-10-03T12:23:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pubblicita-spopolano-i-famaci-per-la-diabesita/ 2023-10-03T13:12:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malaria-oms-raccomanda-vaccino-per-limmunizzazione-dei-bambini-e-il-secondo-disponibile-nel-mondo/ 2023-10-03T13:31:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-una-campagna-per-parlare-di-sessualita-e-tumore-al-seno-metastatico/ 2023-10-03T15:10:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-con-lacquisizione-di-point-biopharma-entra-nel-mercato-dei-radiofarmaci/ 2023-10-04T09:08:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-janssen-insieme-per-sviluppare-vaccino-contro-e-coli/ 2023-10-04T09:39:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-nobel-per-la-chimica-2023-agli-scopritori-dei-quantum-dot/ 2023-10-04T10:53:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-pharma-fino-al-2030-crescita-al-4-annuale/ 2023-10-04T14:56:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/progetto-more-focus-sullo-stato-dellarte-della-salute-mentale-in-italia/ 2023-10-04T16:20:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-con-risdiplam-81-neonati-con-sma-in-piedi-dopo-un-anno-di-trattamento/ 2023-10-05T08:00:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giornata-mondiale-della-meningite-sondaggio-internazionale-ipsos-ancora-scarsa-la-consapevolezza-italia-in-controtendenza-9-genitori-su-10-si-affidano-al-pediatra-per-le-scelte-di-vaccinazione/ 2023-10-05T10:21:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dopo-lo-spin-off-da-novartis-sandoz-vale-11-miliardi-di-dollari/ 2023-10-05T12:58:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-partnership-con-teva-per-farmaco-ibd/ 2023-10-05T13:36:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cattani-linnovazione-tecnologica-guidera-lo-sviluppo-di-nuove-competenze-e-nuovi-bisogni/ 2023-10-06T15:18:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-acquisisce-mitokinin-e-allarga-il-focus-sulle-malattie-neurodegenerative/ 2023-10-06T08:45:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-valuta-lacquisizione-di-mirati-therapeutics/ 2023-10-06T09:21:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-aumenta-la-produzione-di-coniugati-anticorpo-farmaco/ 2023-10-06T09:55:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-rivede-regole-di-trasparenza-per-il-sistema-informativo-dellue-sulle-sperimentazioni-cliniche/ 2023-10-06T12:45:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-completa-lacquisizione-di-horizon-therapeutics/ 2023-10-06T13:38:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vicenda-cannabidiolo-dopo-la-sentenza-del-tar-ministero-della-salute-si-costituisce-parte-civile/ 2023-10-06T15:13:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-aifa-approva-rimborsabilita-di-farcimab-per-namd-e-dme/ 2023-10-09T09:19:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-buoni-risultati-per-il-vaccino-combinato-antinfluenzale-covid-19/ 2023-10-09T12:31:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lindia-entra-nel-pdg-verso-una-farmacopea-internazionale-comune/ 2023-10-09T12:52:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pipeline-oncologica-trainata-dalle-small-cap/ 2023-10-09T13:41:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-beneficio-significativo-e-duratura-da-eplontersen-fino-a-85-settimane-di-trattamento-nella-polineuropatia-amiloide-ereditaria-da-transtiretina/ 2023-10-09T15:04:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-acquisisce-mirati-therapeutics/ 2023-10-10T09:39:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-partnership-per-promuovere-in-cina-il-vaccino-shingrix/ 2023-10-10T16:48:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giornata-mondiale-salute-mentale-oms-europa-cambiare-paradigma-assistenza/ 2023-10-10T14:49:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-connections-individuare-nuovi-percorsi-per-loncologia-del-futuro/ 2023-10-10T15:20:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/incyte-vitiligine-un-tour-per-conoscerla-e-abbattere-i-pregiudizi/ 2023-10-13T15:24:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-apre-uno-stabilimento-in-california-per-produrre-terapie-cellulari/ 2023-10-11T10:01:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-il-nih-finanzia-la-ricerca-su-tre-farmaci-sperimentali-per-la-sla/ 2023-10-11T12:21:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-chiude-anticipatamente-studio-su-ozempic-obiettivo-centrato/ 2023-10-12T09:07:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/congresso-ectrims-focus-biogen-sulla-sm-in-italia/ 2023-10-12T10:35:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bd-diastasi-addominale-patologie-sottovalutata-e-sottostimata/ 2023-10-12T12:55:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/crispr-un-decennio-dopo-lo-stato-dellarte-dellediting-genetico/ 2023-10-12T15:13:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/premiati-i-vincitori-della-xii-edizione-dei-bandi-gilead-ricerca-e-associazioni-al-centro-della-scena/ 2023-10-13T07:49:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bracco-imaging-da-chmp-parere-positivo-per-gadopiclenol/ 2023-10-13T10:15:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/small-molecule-per-nsclc-chi-guidera-il-mercato-alla-fine-del-decennio/ 2023-10-13T13:03:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ssn-inflazione-covid-e-cambiamenti-climatici-potrebbero-metterlo-in-ginocchio/ 2023-10-16T09:28:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ok-chmp-a-elrexfio-nel-rrmm/ 2023-10-16T16:28:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-da-chmp-via-libera-a-keytruda-nel-trattamento-il-cancro-gastrico-e-della-giunzione-gastroesofagea/ 2023-10-16T16:27:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-corregge-verso-lalto-le-stime-per-il-2023/ 2023-10-16T16:26:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-pubblica-survey-fra-aziende-farmaceutiche-su-processi-e-interazioni-con-gli-uffici-dellarea-autorizzazioni/ 2023-10-16T13:28:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/recordati-milan-zdravkovic-e-il-nuovo-executive-vice-president-of-rd/ 2023-10-16T13:43:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-data-factory-presenta-best-svolta-epocale-per-il-monitoraggio-dei-consumi-in-farmacia-attraverso-dati-ufficiali-di-sell-out-delle-farmacie-italiane/ 2023-10-16T15:02:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk13-miliardi-di-dollari-a-kbp-biosciences-per-il-farmaco-ocedurenone/ 2023-10-17T15:02:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-da-fda-via-libera-a-velsipity-nella-colite-ulcerosa/ 2023-10-18T08:24:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-sale-il-tetto-di-spesa-della-diretta-e-scende-quello-della-territoriale/ 2023-10-17T14:52:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-iptacopan-riduce-proteinuria-clinicamente-rilevante-nei-pazienti-con-nefropatia-iga/ 2023-10-18T07:23:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-anna-celleri-a-capo-del-dipartimento-hr-mondiale/ 2023-10-18T15:52:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-al-via-il-bando-per-i-servizi-in-oftalmologia/ 2023-10-18T16:02:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-lormone-della-crescita-somatrogon-passa-da-somministrazione-giornaliera-a-settimanale/ 2023-10-19T07:31:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-teplizumab-rallenta-la-progressione-del-diabete-di-tipo-1-di-stadio-3-in-bambini-e-adolescenti-di-nuova-diagnosi/ 2023-10-19T09:44:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ai-in-sanita-oms-pubblica-guida-per-regolamentarla/ 2023-10-19T12:58:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-ok-a-keytruda-per-luso-pre-e-post-chirurgico-nel-cancro-al-polmone/ 2023-10-19T17:03:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-investira-in-italia-750-milioni-di-euro-entro-il-2025/ 2023-10-19T12:55:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-acquisisce-mablink-bioscience-per-espandere-la-linea-adc/ 2023-10-20T09:05:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-rivede-al-rialzo-le-previsioni-per-il-2023/ 2023-10-20T09:30:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-new-york-il-terzo-biohub-della-chan-zuckerberg-initiative/ 2023-10-21T14:36:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-investe-in-piemonte-oltre-100-mln-di-euro-per-ampliare-il-polo-di-ivrea/ 2023-10-20T15:42:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sapienza-e-sics-insieme-per-il-corso-di-alta-formazione-sullomnichannel-in-lifescience/ 2023-10-20T16:07:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-fondazione-consulcesi-vince-lasta-per-barbie-bebe-i-proventi-allart4sport-della-campionessa-paralimpica/ 2023-10-22T07:02:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/herpes-zoster-in-lombardia-il-40-si-vaccinerebbe-se-ricevesse-piu-informazioni/ 2023-10-23T13:33:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-alectinib-riduce-il-rischio-di-recidiva-o-decesso-del-76-nei-pazienti-con-nsclc-alk-positivo-in-stadio-iniziale-dopo-resezione-chirurgica/ 2023-10-23T13:43:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-esperti-proteggere-i-fragili-gia-in-ospedale-contro-influenza-e-zoster/ 2023-10-23T10:23:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-acquisisce-telavant-holdings-per-71-miliardi-di-dollari/ 2023-10-23T16:04:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-accordo-con-daiichi-sankyo-per-tre-potenziali-adc/ 2023-10-23T12:55:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ribociclib-riduce-il-rischio-di-recidive-in-tutti-i-sottogruppi-dello-studio-natalee-tumore-alla-mammella/ 2023-10-24T07:44:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-elecsys-il-6-primo-test-immunologico-approvato-per-coadiuvare-la-diagnosi-di-sepsi-nei-neonati/ 2023-10-24T09:49:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-nel-nsclc-datopotamab-deruxtecan-migliora-la-sopravvivenza-libera-da-progressione-rispetto-alla-chemioterapia-in-pazienti-precedentemente-trattati/ 2023-10-24T10:25:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/carcinoma-mammario-hr-positivo-her2-low-o-negativo-datopotamab-deruxtecan-prolunga-la-sopravvivenza-libera-da-progressione-rispetto-alla-chemioterapia/ 2023-10-24T14:06:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-da-tre-studi-dati-positivi-per-amivantamab-nel-nsclc/ 2023-10-24T12:44:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/carenza-farmaci-nuovi-strumenti-messi-a-disposizione-dallema/ 2023-10-24T14:59:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-e-sandoz-primi-risultati-finanziari-dopo-lo-spin-off/ 2023-10-25T09:25:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bpco-indagine-doxa-fra-gli-pneumologi-dopo-il-covid-pazienti-piu-attenti-ai-primi-sintomi/ 2023-10-25T09:42:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-fda-regolamenta-la-comunicazione-sulluso-off-label-dei-farmaci/ 2023-10-25T10:47:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/venture-capital-usa-raccoglie-43-miliardi-di-dollari-per-investimenti-in-start-up/ 2023-10-25T12:26:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/paola-di-matteo-nominata-regeneron-medical-director-oncology-in-italy/ 2023-10-26T08:06:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ge-healthcare-e-novo-nordisk-collaborazione-per-trattamento-non-invasivo-per-diabete-di-tipo-2-e-obesita/ 2023-10-26T09:43:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-si-sposta-a-milano-il-nuovo-headquarter-dellazienda-nel-quartiere-bicocca/ 2023-10-26T10:17:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anche-google-cloud-nelle-life-sciences-partnership-con-insmed/ 2023-10-26T13:48:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-nice-raccomanda-per-la-prima-volta-un-farmaco-per-il-parkinson/ 2023-10-27T13:16:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nanomolecole-ad-astrazeneca-la-tecnologia-ai-di-nanoform/ 2023-10-27T10:17:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-deucravacitinib-mostra-efficacia-duratura-e-sicurezza-costante-fino-a-tre-anni-nella-psoriasi-a-placche-da-moderata-a-severa/ 2023-10-27T10:41:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-italia-il-nuovo-value-access-director-e-gianfranco-valenzano/ 2023-10-27T12:31:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anche-sanofi-scorpora-la-unit-consumer-healthcare/ 2023-10-30T16:48:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-global-rare-diseases-un-rapporto-sugli-oneri-per-la-cura-delle-malattie-rare-e-il-loro-impatto-economico-per-i-cittadini-europei/ 2023-10-30T10:29:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/esofagite-eosinofila-studio-di-fase-3-dimostra-unefficacia-sostenuta-di-dupilumab-fino-a-1-anno-nel-trattamento-dei-bambini-da-1-a-11-anni/ 2023-10-30T11:11:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-domenico-de-paolis-nuovo-vp-internazionale-della-divisione-neuromodulation/ 2023-10-30T16:48:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-da-studio-escape-trd-nuovi-dati-di-efficacia-per-esketamina-spray-nasale-nella-depressione-maggiore-resistente-al-trattamento/ 2023-10-30T15:06:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-lettera-dintenti-con-galapagos-per-acquisire-lattivita-di-jyseleca/ 2023-10-31T10:04:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-regno-unito-stanzia-100-mln-di-sterline-per-lo-sviluppo-di-nuovi-farmaci-basati-sullai/ 2023-10-31T10:38:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-verso-un-mercato-europeo-competitivo-e-sostenibile/ 2023-10-31T16:36:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-nuovo-investimento-nellediting-genetico/ 2023-11-02T10:05:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novavax-via-libera-ce-a-nuvaxovid-xbb-1-5-per-il-covid/ 2023-11-02T10:38:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-ottiene-lapprovazione-della-fda-per-il-biosimilare-di-stelara/ 2023-11-02T16:34:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-andrea-damato-alla-guida-del-sito-produttivo-di-rosia/ 2023-11-02T16:33:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-nel-q3-lutile-operativo-e-aumentato-del-64/ 2023-11-03T15:53:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-e-gsk-q3-targato-glp-1/ 2023-11-03T16:27:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-avvia-selezione-esperti-indipendenti-e-rappresentanti-dei-pazienti-per-i-comitati-tecnici/ 2023-11-03T14:48:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/beyond-traceability-il-documento-afi-che-delinea-la-road-map-della-tracciabilita-del-farmaco-in-italia/ 2023-11-06T08:05:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alexander-hardy-nuovo-ceo-di-biomarin-dal-1dicembre/ 2023-11-06T11:19:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-rivede-loutlook-per-il-2023/ 2023-11-06T10:01:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lundbeck-italia-a-roma-storie-di-ordinario-cervello-quattro-film-cult-per-parlare-di-salute-mentale/ 2023-11-06T17:10:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/frontiers-health-2023-al-via-a-roma-per-un-confronto-sulla-trasformazione-digitale-del-ssn/ 2023-11-06T14:28:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/effetto-covid-anche-biontech-taglia-loutloook-per-il-2023/ 2023-11-07T15:49:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-nuova-acquisizione-nel-campo-degli-adc/ 2023-11-07T10:26:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sviluppo-di-linee-cellulari-un-decennio-di-forte-crescita/ 2023-11-07T13:51:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-lefficacia-di-ozanimod-bms/ 2023-11-07T17:26:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medicina-narrativa-pubblicato-car-t-le-storie-dei-pazienti-terzo-volume-del-progetto-cell-therapy-open-source/ 2023-11-08T14:26:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-completa-lacquisizione-di-intercept/ 2023-11-08T14:30:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-apre-un-nuovo-centro-per-le-life-sciences-in-cina/ 2023-11-08T11:02:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-disco-verde-fda-per-tirzepatide-nel-trattamento-dellobesita/ 2023-11-09T08:07:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-alza-le-stime-sul-fatturato-ma-taglia-le-previsioni-sugli-utili/ 2023-11-09T08:40:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-un-q3-superiore-alle-stime/ 2023-11-09T10:15:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/manovra-cattani-farmindustria-in-un-contesto-economico-cosi-difficile-bene-riallocare-risorse-dove-mancano/ 2023-11-10T11:09:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-continua-a-investire-negli-impianti-di-produzione/ 2023-11-13T09:33:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aiom-il-paziente-oncologico-non-parla-di-vaccinazioni-con-lo-specialista-solo-1-su-10-sa-che-il-vaccino-per-lherpes-zoster-e-raccomandato/ 2023-11-13T10:18:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-glp-1-astrazeneca-acquisisce-candidato-dalla-biotech-cinese-eccogene/ 2023-11-13T13:18:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valneva-fda-approva-vaccino-contro-la-chikungunya/ 2023-11-13T13:59:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-parere-positivo-chmp-per-momelotinib-nella-terapia-della-mielofibrosi/ 2023-11-14T10:11:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-nuovi-dati-su-wegovy-nella-riduzione-del-rischio-cardiovscolare/ 2023-11-14T13:42:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-aifa-a-rimborsabilita-pertuzumab-in-adiuvante/ 2023-11-14T13:30:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-accordo-con-legend-biotech-per-terapia-car-t-nel-tumore-al-polmone/ 2023-11-14T14:12:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/confindustria-dm-bene-miniproroga-al-30-novembre/ 2023-11-14T15:51:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-chmp-raccomanda-lapprovazione-della-formulazione-sottocutanea-di-tecentriq/ 2023-11-15T10:04:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-ok-ce-a-vanflyta-nella-aml-positiva-a-flt3-itd-di-nuova-diagnosi/ 2023-11-15T10:29:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-parere-positivo-chmp-per-talzenna-nei-pazienti-adulti-con-cancro-alla-prostata-metastatico-resistente-alla-castrazione/ 2023-11-15T10:58:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-2024-gli-hcp-tornano-al-centro-della-scena/ 2023-11-15T14:53:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hta-dispositivi-medici-schillaci-litalia-e-pronta-ad-accogliere-la-sfida-che-viene-dalleuropa/ 2023-11-15T15:08:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-sell-out-e-articolo-34-la-farmacia-come-one-voice-per-il-nuovo-monitoraggio-dei-farmaci-e-dei-dispositivi-medici-il-24-novembre-levento-organizzato-da-pharma-data/ 2023-11-16T12:46:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/italiani-preoccupati-per-la-salute-la-risposta-di-novartis-italia/ 2023-11-16T16:01:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-del-polmone-per-una-vera-prevenzione-screening-estesi-e-una-maggiore-informazione/ 2023-11-16T13:35:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-investe-175-milioni-di-euro-in-due-nuovi-impianti/ 2023-11-16T14:13:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-equivalenti-aziende-strette-tra-lincudine-dei-prezzi-e-il-martello-dei-costi-produttivi/ 2023-11-16T15:22:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-presto-un-grande-impianto-di-produzione-in-germania/ 2023-11-17T10:03:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-acquisisce-propella-therapeutics-per-175-milioni-di-dollari/ 2023-11-17T10:19:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-da-uk-via-libera-al-primo-farmaco-crispr/ 2023-11-17T10:58:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-ok-aifa-a-rimborsabilita-axicel-per-due-nuove-indicazioni/ 2023-11-17T16:07:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumori-in-11-anni-limmunoncologia-ha-evitato-4-mila-morti-il-progetto-li-on-di-bms/ 2023-11-20T17:40:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-e-haisco-pharmaceutical-accordo-per-sviluppare-e-commercializzare-nuovo-dpp1-per-le-malattie-respiratorie/ 2023-11-20T13:41:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-ce-estende-approvazione-lanadelumab-ai-pazienti-pediatrici-con-per-la-prevenzione-degli-attacchi-di-angioedema-ereditario/ 2023-11-20T15:47:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/canali-distributivi-del-farmaco-on-line-il-documento-congiunto-sifo-fofi-federfarma-e-assofarm/ 2023-11-20T15:17:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/almirall-ce-approva-lebrikizumab-per-la-dermatite-atopica/ 2023-11-20T15:34:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/efpia-serve-modello-di-incentivi-per-produzione-nuovi-antibiotici-si-a-voucher-di-esclusiva-trasferibili/ 2023-11-21T10:02:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-nasce-evinova-la-unit-per-la-salute-digitale/ 2023-11-21T15:44:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-accordo-con-il-giappone-per-vaccino-anti-covid/ 2023-11-21T13:19:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuova-collaborazione-per-luso-dellai-nello-sviluppo-dei-farmaci-e-la-volta-di-genentech-nvidia/ 2023-11-22T15:54:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-acquisisce-caraway-therapeutics-biotech-specializzata-nelle-neuroscienze/ 2023-11-22T10:47:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-verso-linalatore-per-asma-net-zero/ 2023-11-22T11:12:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/premio-letterario-afiancodelcoraggio-per-parlare-dei-caregiver-uomini-proclamati-i-vincitori-della-sesta-edizione/ 2023-11-22T14:46:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-al-via-la-campagna-nuove-opzioni-nuovi-percorsi-per-fare-awareness-su-tumore-al-polmone/ 2023-11-22T15:30:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-acquisisce-t3-pharma-biotech-focalizzata-sullimmuno-oncologia/ 2023-11-23T10:55:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-sciences-parte-la-campagna-di-sensibilizzazione-hiv-ne-parliamo/ 2023-11-23T14:40:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cancro-dellendometrio-via-libera-europeo-alla-combinazione-immunoterapia-chemioterapia-in-prima-linea/ 2023-11-23T14:44:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/healthbiotech-summit-2023-innovare-per-una-sanita-piu-sostenibile/ 2023-11-23T15:51:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-acquisisce-inibitore-kras-per-la-pipeline-oncologica/ 2023-11-24T10:27:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anche-almirall-sceglie-lia-per-scoprire-nuovi-farmaci/ 2023-11-24T10:50:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/violenza-di-genere-nelle-aziende-pharma-incontri-periodici-con-i-dipendenti-e-le-dipendenti-per-dare-informazioni-sul-rispetto-della-dignita-delle-donne-e-di-ogni-persona/ 2023-11-24T13:32:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-ecco-cosa-produrra-il-nuovo-sito-da-2-5-miliardi-di-dollari/ 2023-11-24T15:44:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/payback-dispositivi-medici-pagamenti-rimangono-sospesi-tar-lazio-solleva-questioni-di-legittimita-costituzionale/ 2023-11-24T15:53:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/innovazioni-in-sanita-digitale-premiati-gli-8-vincitori-delliniziativa-di-agenas-sics/ 2023-11-24T16:18:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-ok-ema-a-variazione-aic-per-kaftrio-fibrosi-cistica/ 2023-11-25T15:01:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-amplia-sito-di-produzione-francese/ 2023-11-27T11:13:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-da-oggi-disponibile-anche-in-italia-olipudasi-alfa-per-lasmd/ 2023-11-27T11:33:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mieloma-multiplo-la-combinazione-belantamab-bortexomib-e-desametasone-aumenta-la-sopravvivenza-libera-da-malattia/ 2023-11-27T12:25:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-e-sanofi-nuova-richiesta-a-fda-per-dupixent/ 2023-11-28T10:07:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/riforma-aifa-commissioni-tecniche-in-scadenza-1-dicembre-verso-regime-prorogatio-45-giorni/ 2023-11-28T16:13:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cellule-staminali-per-la-sm-bene-la-fase-i-dello-studio-first-in-human-guidato-da-angelo-vescovi/ 2023-11-28T14:05:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-collaborazione-e-innovazione-gilead-sciences-italia-fotografata-da-the-european-house-ambrosetti/ 2023-11-28T16:09:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/health-innovation-show-a-napoli-il-road-show-sullinnovazione-sanitaria/ 2023-11-29T16:16:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-accordo-con-avidity-biosciences-per-la-pipeline-cardiovascolare/ 2023-11-29T11:13:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-usera-il-modello-genai-di-ibm-per-lo-sviluppo-di-anticorpi/ 2023-11-29T13:13:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-si-conclude-il-viaggio-triennale-della-campagna-educazionale-la-smagliante-ada/ 2023-11-29T14:20:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/innovaction-global-health-e-salute-del-futuro-la-via-della-prevenzione-2-0/ 2023-11-29T14:54:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-e-msd-aifa-approva-rimborsabilita-di-olaparib-tumore-del-seno/ 2023-11-30T13:52:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/beigene-aifa-approva-due-nuove-indicazioni-per-zanubrutinib/ 2023-11-30T14:31:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/per-la-genai-amgen-sceglie-amazon/ 2023-11-30T15:24:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-dialogo-con-cina-e-india-per-luso-dellenergia-rinnovabile-nelle-catene-di-approvvigionamento/ 2023-11-30T16:10:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-nuovo-big-deal-abbvie-acquisisce-immunogen-per-10-miliardi-di-dollari/ 2023-12-03T10:24:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viatris-allindiana-biocon-il-business-dei-biosimilari-in-europa/ 2023-12-01T09:09:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-600-milioni-di-dollari-per-la-piattaforma-discovery-drug-di-prism-biolab/ 2023-12-01T09:46:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-fda-apre-indagine-sul-rischio-di-cancro-correlato-alle-terapie-cart/ 2023-12-03T09:52:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-approvazione-accelerata-fda-per-jaypirca-llc/ 2023-12-04T11:18:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/distrofie-ereditarie-della-retina-nasce-geni-in-vista-il-nuovo-sito-di-janssen-dedicato-ai-pazienti/ 2023-12-04T11:52:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-focus-sui-farmaci-agonisti-del-glp1/ 2023-12-04T13:45:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-un-sito-produttivo-dedicato-ai-farmaci-per-la-radioterapia/ 2023-12-04T14:18:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cop28-ifpma-cambiamento-climatico-sfida-sanitaria-urgente/ 2023-12-04T14:38:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-chiesi-una-serie-con-bbc-storyworks-per-parlare-di-persone-con-patologie-respiratorie-e-cambiamenti-climatici/ 2023-12-05T09:55:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-entra-nel-campo-dei-trattamenti-per-lobesita-con-lacquisizione-di-carmot-therapeutics/ 2023-12-05T10:25:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-e-absci-partnership-per-anticorpo-oncologico-progettato-da-ai/ 2023-12-05T11:04:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gavi-introduce-nuovi-programmi-vaccinali/ 2023-12-05T13:49:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-entro-il-2030-venti-nuove-terapie-sul-mercato/ 2023-12-06T10:44:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-sciences-aifa-autorizza-rimborsabilita-brexu-cel-nella-leucemia-linfoblastica-acuta/ 2023-12-06T11:40:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-lancia-il-nuovo-rebranding-aziendale/ 2023-12-06T13:56:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-e-valneva-parte-fase-3-studio-vaccino-della-malattia-di-lyme/ 2023-12-06T14:16:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/consumo-dei-farmaci-pharma-data-factory-presenta-la-soluzione-best/ 2023-12-06T18:02:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbivie-shopping-miliardario-nelle-neuroscienze-acquisita-cerevel-therapeutics/ 2023-12-11T10:29:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fujifilm-200-milioni-di-dollari-per-produrre-terapie-cellulari/ 2023-12-11T10:54:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cancro-dellendometrio-commissione-ue-approva-dostarlimab-in-prima-linea-con-chemio/ 2023-12-11T11:37:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-ok-a-due-terapie-geniche-contro-lanemia-falciforme/ 2023-12-11T13:39:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/carenze-farmaci-autorita-regolatorie-globali-aumentano-sforzi-per-garantire-disponibilita-continua-prodotti-sicuri-e-di-qualita/ 2023-12-11T14:07:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-e-moderna-presto-il-via-a-studio-fase-iii-del-vaccino-per-nsclc/ 2023-12-12T10:33:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lamerican-cancer-society-a-fianco-delle-big-pharma-per-potenziare-lo-screening-del-tumore-al-polmone/ 2023-12-12T10:32:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-al-via-pahssaparola-campagna-social-dedicata-allipertensione-arteriosa-polmonare/ 2023-12-12T11:21:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-tutti-i-progressi-in-oncologia-25-molecole-su-92-in-attesa-del-parere-da-parte-di-ema-sono-antineoplastiche/ 2023-12-12T17:09:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-riceve-tutte-le-approvazioni-normative-necessarie-per-completare-lacquisizione-di-seagen/ 2023-12-12T12:52:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/riforma-aifa-consiglio-di-stato-trasmette-parere-regolamento-conforme-ma-valutare-regola-di-esclusivita-per-il-presidente-al-via-il-valzer-delle-nomine/ 2023-12-12T17:09:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genentech-ashley-magargee-confermata-nella-carica-di-ceo/ 2023-12-13T09:38:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-acquisisce-icosavax-per-rinforzare-la-pipeline-dei-vaccini/ 2023-12-13T12:00:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-continua-a-investire-negli-adc-800-miloni-per-candidato-di-systimmune/ 2023-12-19T09:18:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-biologici-oltre-il-gap-della-distribuzione/ 2023-12-13T14:37:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-partita-la-costruzione-del-sito-per-biosimilari-in-europa/ 2023-12-13T14:59:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-approvata-la-prima-versione-dellelenco-ue-dei-medicinali-fondamentali-per-evitare-potenziali-carenze/ 2023-12-13T15:45:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-italia-claudio-longo-nuovo-presidente-e-amministratore-delegato/ 2023-12-14T11:57:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-aifa-rinnova-per-il-terzo-anno-consecutivo-il-riconoscimento-di-innovativita-piena-a-zolgensma-prima-terapia-genica-per-la-sma/ 2023-12-14T13:16:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/path-join-our-future-ascoltare-la-voce-del-paziente-attraverso-i-dati-sanitari/ 2023-12-14T16:03:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/confindustria-dispositivi-medici-nicola-barni-e-il-nuovo-presidente/ 2023-12-14T17:06:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/2024-ecco-i-principali-trend-di-investimento-tecnologico/ 2023-12-15T10:28:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ssn-per-garantire-servizio-universalistico-serve-investire-sul-territorio-e-su-partnership-pubblico-privato/ 2023-12-22T08:50:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-via-libera-da-ema-a-casgevy-prima-terapia-che-utilizza-lediting-genetico-crispr/ 2023-12-18T09:35:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-chmp-raccomanda-omaveloxolone-per-il-trattamento-dellatassia-di-friedreich/ 2023-12-19T09:17:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-e-biolojic-accordo-per-sviluppare-terapia-a-base-di-anticorpi-per-asma-e-dermatite-atopica/ 2023-12-18T10:31:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-jay-bradner-e-il-nuovo-chief-scientific-officer/ 2023-12-18T11:47:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-e-moderna-risultati-positivi-per-la-combo-vaccino-mrna-keytruda-nel-melanoma/ 2023-12-18T13:34:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dispositivi-medici-in-manovra-non-ce-stato-spazio-per-risolvere-payback-aperti-a-dialogo-dal-nuovo-anno-forti-della-sentenza-tar-intervista-a-barni-neopresidente-confindustria-dm/ 2023-12-18T15:46:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-chiesi-il-59-oscar-di-bilancio-per-la-categoria-societa-benefit/ 2023-12-19T09:34:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/organon-acquisisce-i-diritti-europei-di-due-farmaci-per-lemicrania-di-eli-lilly/ 2023-12-19T10:45:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-novo-nordisk-260-milioni-di-dollari-per-la-rs-dei-vaccini-per-le-malattie-respiratorie/ 2023-12-19T10:52:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-dagli-studi-glow-e-captivate-buoni-risultati-per-la-combo-ibrutinib-piu-venetoclax-come-trattamento-di-prima-linea-nella-leucemia-linfatica-cronica/ 2023-12-19T12:31:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/intelligenza-artificiale-e-farmaci-da-ema-piano-di-lavoro-2028-per-guidarne-luso-nella-regolamentazione-dei-medicinali/ 2023-12-19T13:12:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumori-delle-vie-biliari-in-italia-5400-nuovi-casi-allanno-lefficacia-di-durvalumab/ 2023-12-19T15:39:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid-covax-concludera-il-suo-lavoro-il-31-dicembre-consegnate-quasi-2-miliardi-di-dosi-per-27-milioni-di-morti-evitate/ 2023-12-20T10:29:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otsuka-commercializzera-in-europa-candidato-per-langioedema-ereditario-di-ionis/ 2023-12-20T10:38:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-tutto-il-patrimonio-informativo-su-polo-strategico-nazionale/ 2023-12-20T11:22:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ibsa-italy-sponsor-della-as-roma-calcio-femminile/ 2023-12-20T11:45:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-da-fda-priority-review-a-omalizumab-per-le-allergie-alimentari/ 2023-12-21T10:09:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-accordo-con-biotech-cinese-per-candidato-adc/ 2023-12-21T10:37:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/b-braun-sceglie-alessandro-corsi-per-la-carica-di-medical-scientific-affairs-manager/ 2023-12-21T11:31:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-ema-pubblica-report-di-medio-termine-sulla-buona-strada-per-raggiungere-i-nostri-obiettivi/ 2023-12-21T13:37:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-scommette-sulla-terapia-genica-oculare-di-meiragtx/ 2023-12-22T16:21:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-nice-raccomanda-combo-per-il-tumore-della-prostata/ 2023-12-22T10:41:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-fda-rinnova-le-linee-guida-eua-per-gli-anticorpi-monoclonali/ 2023-12-22T11:24:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-nuova-partnership-per-la-terapia-dellobesita/ 2023-12-22T14:51:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tempi-di-accedal-secondo-documento-prodotto-dal-think-thank-ithaca-una-proposta-per-un-nuovo-meccanismo-di-early-access/ 2023-12-22T16:00:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/goldman-sachs-entra-nel-biotech-con-un-fondo-venture-capital/ 2024-01-09T09:34:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-partnership-con-remix-per-sviluppare-farmaci-che-agiscono-sullrna/ 2024-01-08T11:41:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-completa-lacquisizione-di-jyseleca-da-galapagos/ 2024-01-08T13:33:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-accordo-con-insilico-per-inibitore-kat6-del-carcinoma-mammario/ 2024-01-08T14:20:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/csl-seqirus-ce-estende-vaccino-antinfluenzale-quadrivalente-adiuvato-ai-5064enni/ 2024-01-09T10:53:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-investe-anche-negli-usa-164-mld-di-dollari-per-startup-a-stelle-e-strisce/ 2024-01-09T17:11:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/neonatologia-accordo-tra-gruppo-chiesi-e-oak-hill-bio-per-sviluppare-candidato-per-le-complicanze-dellestrema-prematurita/ 2024-01-09T13:37:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jpm-2024-jj-msd-e-novartis-annunciano-tre-acquisizioni/ 2024-01-09T14:49:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-via-libera-ce-a-talzenna-nei-pazienti-adulti-con-cancro-alla-prostata-metastatico-resistente-alla-castrazione/ 2024-01-09T15:28:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ucb-ce-approva-rystiggo-per-la-miastenia-gravis/ 2024-01-10T16:43:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-acquisisce-aiolos-bio-per-un-mld-di-dollari/ 2024-01-10T16:43:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/non-solo-covid-dallo-streptococco-alla-vitamina-d-ormai-e-boom-di-test-fai-da-te-in-farmacia/ 2024-01-10T12:30:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/obesita-arriva-un-nuovo-player-sul-mercato/ 2024-01-10T13:57:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-approva-studio-pilota-sulle-malattie-neurodegenerative/ 2024-01-11T10:29:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-lancia-nella-ue-farmaco-per-il-trattamento-del-parkinson-a-infusione-sottocutanea/ 2024-01-11T16:09:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/degenerazione-maculare-un-mercato-da-275-miliardi-di-dollari/ 2024-01-11T13:59:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mirati-da-commissione-europea-via-libera-a-krazati-nel-nsclc-kras-mutato/ 2024-01-12T10:00:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/arriva-in-europa-il-primo-biosimilare-di-stelara/ 2024-01-12T10:46:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novavax-vaccino-aggiornato-covid19-induce-crossneutralizzazione-contro-variante-jn-1/ 2024-01-12T11:09:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogeneisai-approvazione-leqembi-chmp-chiede-consulenza-esterna/ 2024-01-12T13:38:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-da-ema-nuove-misure-precauzionali-su-valproato-nei-pazienti-maschi-e-revisione-su-rischio-tumori-secondari-con-terapie-cart/ 2024-01-12T15:17:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/consip-confindustria-dm-sottoscritto-protocollo-di-collaborazione-istituzionale-nel-settore-degli-approvvigionamenti-sanitari/ 2024-01-15T10:42:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-120-milioni-di-euro-per-espandere-la-produzione-in-europa/ 2024-01-15T11:08:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-ed-eli-lilly-il-derby-dellobesita/ 2024-01-15T14:18:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/riforma-aifa-il-decreto-con-il-nuovo-regolamento-pubblicato-in-gazzetta-in-vigore-dal-30-gennaio/ 2024-01-16T09:27:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-da-fda-terza-indicazione-per-keytruda-nel-tumore-dellutero/ 2024-01-16T10:02:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ce-approva-atezolizumab-in-formulazione-sottocutanea/ 2024-01-16T10:27:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-nessun-legame-tra-i-farmaci-glp-1-e-suicidio/ 2024-01-16T13:47:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-punta-forte-sugli-adc-per-la-pipeline-oncologica/ 2024-01-17T10:13:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-da-fda-nuova-approvazione-per-hyqvia/ 2024-01-17T10:50:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/csl-behring-la-terapia-genica-hemgenix-vince-il-prix-galien-usa-2023-come-miglior-prodotto-per-le-malattie-rare-orfane/ 2024-01-17T14:40:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-di-precisione-efpia-lancia-la-sua-visione-nellanno-delle-elezioni-europee/ 2024-01-17T13:32:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-focus-2024-sui-farmaci-innovativi/ 2024-01-18T10:38:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/becton-dickinson-si-aggiudica-anche-per-il-2024-la-certificazione-top-employers-italia/ 2024-01-19T09:13:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sun-pharma-acquisiscetaro-pharmaceutical/ 2024-01-19T09:46:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-autorizza-dispositivo-portatile-ai-di-rilevamento-del-cancro-della-pelle/ 2024-01-19T14:44:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-il-mercato-in-farmacia-cresce-del-23-a-17-mld-e-17-mld-di-confezioni-vendute-nel-2023/ 2024-01-19T13:16:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/2023-annus-horribilis-per-gli-investimenti-nel-biotech/ 2024-01-19T13:52:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-durvalumab-piu-tace-e-bevacizumab-riduce-il-rischio-di-progressione-di-malattia-o-di-morte-del-23-rispetto-a-tace-nel-tumore-del-fegato-eleggibile-per-lembolizzazione/ 2024-01-19T15:09:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kyowa-kirin-a-julia-blanco-la-direzione-medica-del-southern-cluster/ 2024-01-22T10:16:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-ottimi-risultati-per-la-combo-opdivo-yervoy-nel-tumore-colorettale/ 2024-01-22T10:46:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-riflettori-accesi-su-lutathera/ 2024-01-22T11:36:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-da-aifa-rimborsabilita-per-trastuzumab-deruxtecan-nel-tumore-dello-stomaco-metastatico-her2-positivo/ 2024-01-22T15:39:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ionis-pharmaceuticals-presto-un-nuovo-farmaco-per-langioedema-ereditario/ 2024-01-23T10:34:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genentech-roche-stop-alla-partnership-con-ac-immune-sulle-terapie-per-lalzheimer/ 2024-01-23T11:09:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/csl-behring-in-fda-ed-ema-al-via-la-procedura-per-la-registrazione-di-garadacimab-hae/ 2024-01-23T11:50:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-acquisisce-biosimilare-di-lucentis/ 2024-01-23T14:05:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-ecco-la-top-50-dei-piu-venduti-nelle-farmacie-italiane/ 2024-01-24T08:04:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/per-novo-nordisk-italia-nuova-sede-allinsegna-della-massima-sostenibilita-ambientale/ 2024-01-24T17:48:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-acquisisce-la-biotech-inhibrx-per-22-miliardi-di-dollari/ 2024-01-24T11:31:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genentech-roche-partnership-con-genedit-per-terapie-di-editing-genetico/ 2024-01-24T13:39:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-box-warning-per-le-terapie-cart-sul-rischio-di-neoplasie-secondarie/ 2024-01-24T16:19:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-crescita-record-nel-q4-2023/ 2024-01-25T10:38:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ancora-un-accordo-per-gli-adc-partnership-tra-wuxi-xdc-e-celltrion/ 2024-01-25T11:02:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-a-cg-oncology-la-prima-ipo-del-2024/ 2024-01-25T13:36:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-stefano-sommella-nuovo-oncology-country-head/ 2024-01-25T16:17:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valentino-confalone-novartis-italia-nuovo-chairman-di-eunipharma/ 2024-01-26T14:17:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ok-aifa-a-lorviqua-come-monoterapia-nel-nsclc-in-stadio-avanzato-alk/ 2024-01-26T10:21:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/infodemia-oms-europa-lancia-un-toolkit-operativo-con-5-step/ 2024-01-26T11:31:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/samsung-biologics-un-2023-da-incorniciare/ 2024-01-26T13:54:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-awards-al-via-la-vi-edizione-a-febbraio-il-festival-dellinnovazione-e-l11-aprile-la-celebrazione-dei-best-of-2023/ 2024-01-29T13:21:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-disponibile-e-rimborsabile-avalglucosidasi-alfa-per-la-malattia-di-pompe/ 2024-01-29T15:04:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-223-milioni-di-dollari-per-il-restyling-del-sito-di-singapore/ 2024-01-29T15:08:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-e-nuovo-regolamento-europeo-hta-prospettive-e-proposte-nel-terzo-paper-elaborato-dal-think-tank-ithaca/ 2024-01-29T13:37:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-supportera-la-creazione-della-african-medicines-agency/ 2024-01-29T15:26:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-ok-ce-a-omjjara-per-la-splenomegalia-nella-mielofibrosi/ 2024-01-30T15:09:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medical-device-ge-healthcare-acquisisce-mim-software/ 2024-01-30T10:13:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/apr-un-gioco-da-tavolo-per-spiegare-la-pku/ 2024-01-30T11:23:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-consumer-healthcare-italia-ottiene-la-certificazione-b-corp/ 2024-01-30T11:47:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-pembrolizumab-in-fase-adiuvante-riduce-del-38-di-rischio-di-morte-dopo-nefrectomia-per-tumore-del-rene/ 2024-01-30T18:32:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-leader-nei-vaccini-mrna-contro-le-malattie-infettive/ 2024-01-30T15:03:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-ecco-le-indicazioni-delle-regioni-sui-membri-di-cda-e-commissione-unica-i-nomi/ 2024-01-30T16:04:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-pro4all-pazienti-protagonisti-per-la-salute-di-tutti/ 2024-01-30T16:33:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-acquisisce-la-pipeline-di-terapie-cellulari-di-2seventy/ 2024-01-31T10:06:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-e-daiichi-sankyo-puntano-allapprovazione-agnostica-di-enhertu/ 2024-01-31T11:44:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-collaborazione-con-synthekine-per-lo-sviluppo-di-agonisti-del-recettore-di-il10/ 2024-01-31T11:10:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-q4-2023-in-calo-ma-crescono-i-prodotti-non-covid/ 2024-01-31T14:06:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-e-partito-il-rush-finale-delle-nomine-dal-presidente-ai-direttori-fino-alla-commissione-unica-ecco-i-nomi-in-pole-position/ 2024-01-31T14:12:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-positiva-la-performance-2023-con-10-nelle-vendite-nette-e-18-sullutile-operativo-dellattivita-core/ 2024-01-31T14:21:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-definisce-lacquisizione-di-jyseleca-da-galapagos/ 2024-02-01T07:55:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/incyte-italia-due-nuovi-ingressi-nel-leadership-team/ 2024-02-01T09:31:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biomarin-aifa-approva-rimborsabilita-di-roctavian-prima-terapia-genica-al-mondo-per-lemofilia-a-grave/ 2024-02-01T17:30:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-la-combo-opdivo-yervoy-riduce-il-del-28-il-rischio-di-morte-nel-carcinoma-a-cellule-renali/ 2024-02-01T10:48:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-320-milioni-di-dollari-ad-arcus-per-aumentare-la-quota-di-partecipazione/ 2024-02-01T11:28:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-dati-positivi-per-faricimab-nella-rvo-da-due-studi-internazionali-di-fase-iii/ 2024-02-01T13:56:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/almirall-e-microsoft-partnership-per-lo-sviluppo-di-farmaci-dermatologici/ 2024-02-02T09:46:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-2023-stellare-con-i-farmaci-glp-1/ 2024-02-02T10:08:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spesa-farmaceutica-report-aifa-nei-primi-9-mesi-del-2023-sale-a-164-mld-di-euro/ 2024-02-02T10:21:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/atara-e-pierre-fabre-the-lancet-oncology-pubblica-dati-positivi-su-tabelecleucel-nel-trattamento-della-ptld/ 2024-02-02T11:46:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-italia-e-fvg-accordo-di-collaborazione-per-accelerare-lecosistema-salute-della-regione/ 2024-02-02T13:40:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-la-campagna-playtheraregame-al-sei-nazioni-di-rugby/ 2024-02-02T14:29:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rinnovo-ai-vertici-di-sobi-italia-sette-donne-nel-leadership-team/ 2024-02-05T10:42:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/carenze-di-farmaci-in-europa-il-report-dei-farmacisti-delleu-pgeu/ 2024-02-05T11:11:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-nel-2023-il-fatturato-e-sceso-del-2-eliquis-il-farmaco-piu-venduto/ 2024-02-05T13:37:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-la-riforma-prende-corpo-ecco-i-nomi-dei-componenti-della-nuova-commissione-scientifica-ed-economica/ 2024-02-06T09:16:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-prosegue-la-grande-marcia-acquisita-catalent-per-165-miliardi-di-dollari/ 2024-02-06T09:57:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-prosegue-lo-shopping-2024-acquisita-morphosys/ 2024-02-06T10:46:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-studio-dreamm-7-belantamab-mafodotin-ha-ridotto-del-59-il-rischio-di-malattia-o-morte-nel-mieloma-multiplo-recidivante-refrattario/ 2024-02-06T14:01:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-mounjaro-superstar-in-un-anno-incassati-oltre-5-miliardi-di-dollari/ 2024-02-07T09:49:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-show-dal-laboratorio-alla-comunita-limpegno-sociale-della-filiera-salute/ 2024-02-14T11:18:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-nipocalimab-efficace-contro-la-miastenia-gravis-generalizzata-e-la-malattia-di-sjogren/ 2024-02-07T10:32:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tutte-le-sfide-della-nuova-aifa-intervista-a-guido-rasi/ 2024-02-07T12:20:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-show-innovare-in-medicina-sfide-e-soluzioni-oltre-le-terapie/ 2024-02-14T11:18:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-show-creare-il-futuro-insieme-il-dialogo-tra-industria-centri-di-ricerca-e-stakeholder/ 2024-02-14T11:18:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-la-riforma-al-traguardo-giorgio-palu-verso-la-conferma-al-vertice/ 2024-02-08T14:36:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-300-milioni-di-dollari-per-un-impianto-dedicato-alle-terapie-cellulari/ 2024-02-08T09:51:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jazz-pharmaceuticals-acquisisce-programma-di-inibitori-kras-per-880-milioni-di-dollari/ 2024-02-08T10:33:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-dapagliflozin-efficace-a-lungo-termine-nel-proteggere-i-reni-delle-persone-con-diabete/ 2024-02-08T11:08:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-da-oggi-disponibile-in-italia-polatuzumab-per-il-trattamento-del-linfoma-diffuso-a-grandi-cellule-b/ 2024-02-08T13:52:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-show-connettere-la-scienza-e-il-pubblico-le-nuove-strategie-della-comunicazione-della-salute/ 2024-02-14T11:18:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-show-migliorare-la-cura-con-la-patient-advocacy-un-percorso-di-successo/ 2024-02-14T11:18:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/samsung-biologics-accordo-con-legochem-per-produzione-adc/ 2024-02-10T09:32:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-generici-complessi-al-via-programma-ema-e-fda/ 2024-02-11T16:29:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-cellulari-biontech-sceglie-autolus-therapeutics-per-incrementare-la-produzione/ 2024-02-12T10:38:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-cresce-del-6-il-fatturato-dellanno-fiscale-2023/ 2024-02-13T08:24:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-italia-riceve-la-certificazione-sulla-parita-di-genere/ 2024-02-12T11:35:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-sciences-acquisisce-cymabay-therapeutics/ 2024-02-13T08:40:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-ce-approva-omaveloxolone-per-il-trattamento-dellatassia-di-friedreich/ 2024-02-13T09:47:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-arriva-lok-ce-per-casgevy-prima-terapia-che-utilizza-lediting-genetico-crispr-nella-beta-talassemia-e-nellanemia-falciforme/ 2024-02-13T10:07:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipsen-aifa-approva-rimborsabilita-di-cabozantinib-compresse-per-il-trattamento-del-carcinoma-differenziato-della-tiroide-refrattario-alla-terapia-con-iodio-radioattivo/ 2024-02-13T10:40:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/test-microbiologici-rapidi-un-settore-in-crescita/ 2024-02-13T14:05:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-show-6-innovazione-e-governance-sanitaria-oltre-le-barriere/ 2024-02-14T11:17:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-conclude-lacquisizione-di-immunogen-per-101-miliardi-di-dollari/ 2024-02-14T09:44:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/thermo-fischer-partnership-con-multiply-labs-per-lautomazione-nei-processi-di-produzione-delle-terapie-cellulari/ 2024-02-14T10:07:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-e-pathai-collaborazione-per-la-diagnostica-complementare/ 2024-02-14T10:50:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-show-7-linfluenza-della-digital-health-nel-futuro-dellassistenza-sanitaria/ 2024-02-14T11:22:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-punta-ai-radiofarmaci-di-nuova-generazione-accordo-con-pantera/ 2024-02-15T09:11:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-investe-nei-farmaci-genai/ 2024-02-15T14:33:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-e-hma-lanciano-due-nuovi-cataloghi-di-fonti-e-studi-con-dati-real-world/ 2024-02-15T16:06:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-show-8-omnichannel-strategie-di-successo-nel-ciclo-di-vita-dei-farmaci/ 2024-02-16T15:27:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-show-9-sul-palco-della-salute-il-futuro-di-convegni-e-congressi/ 2024-02-16T08:56:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-e-saama-estendono-laccordo-per-accelerare-la-ricerca-clinica/ 2024-02-16T10:10:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-italia-aderisce-alla-campagna-millumino-di-meno-di-rai-radio-2/ 2024-02-17T10:57:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-approva-prima-terapia-con-cellule-t-per-un-tumore-solido/ 2024-02-19T10:48:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otsuka-breakthrough-therapy-per-sibeprenlimab-dalla-fda-per-la-malattia-di-berger/ 2024-02-19T11:29:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biocryst-pharmaceuticals-da-aifa-rimborsabilita-per-berotralstat-hae/ 2024-02-19T14:30:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/le-vendite-dei-primi-50-farmaci-in-italia-stabili-a-valori-nel-2023-ecco-la-classifica-secondo-le-nuove-stime-pharma-data-factory/ 2024-02-19T15:07:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/almirall-accordo-di-licenza-con-novo-nordisk-per-candidato-anticorpo-il-21/ 2024-02-20T09:19:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-collaborazione-con-la-startup-kelonia-per-realizzare-terapie-cellulari-in-vivo/ 2024-02-20T17:24:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-arriva-in-italia-il-dispositivo-impiantabile-eterna-scs-per-il-dolore-cronico/ 2024-02-20T10:10:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-italia-un-murale-a-milano-per-sensibilizzare-i-cittadini-sulla-meningite/ 2024-02-20T13:03:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-robert-michael-nuovo-ceo-dal-1-luglio/ 2024-02-21T09:24:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ecdc-il-management-board-nomina-nuova-direttrice-pamela-rendi-wagner/ 2024-02-21T09:58:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-iniziativa-per-migliorare-la-bioproduzione-nei-paesi-a-basso-reddito/ 2024-02-21T11:03:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-dati-studio-di-fase-ii-dimostrano-lefficacia-di-frexalimab-nella-sm-recidivante/ 2024-02-21T11:21:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/phrma-il-nuovo-presidente-e-daniel-oday-ceo-di-gilead/ 2024-02-22T09:27:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/salute-e-sanita-devono-essere-una-priorita-per-il-governo-sempre-piu-italiani-la-pensano-cosi/ 2024-02-22T09:29:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antibioticoresistenza-ema-ecdc-ed-efsa-in-europa-emergenza-in-calo-grazie-a-riduzione-consumo/ 2024-02-22T09:55:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-giorgio-palu-si-e-dimesso-dalla-presidenza/ 2024-02-22T11:39:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ok-ce-a-velsipity-nella-cu-attiva-da-moderata-a-grave/ 2024-02-22T11:14:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-farmaco-basato-su-nanotecnologia-aumenta-la-sopravvivenza-nel-tumore-del-pancreas-metastatico/ 2024-02-22T13:22:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/intersystems-italia-nomina-nico-bondi-nuovo-country-manager/ 2024-02-22T14:57:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-prosegue-trend-in-discesa-ma-fiducia-per-il-vaccino-anti-rsv/ 2024-02-23T09:07:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-il-nice-raccomanda-ritlecitinib-primo-farmaco-per-lalopecia-areata-grave/ 2024-02-23T09:36:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-fda-a-combo-tagrisso-chemioterapia-nel-nslc-con-mutazione-egfr/ 2024-02-23T10:15:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-parere-positivo-chmp-per-tofersen-nella-sla/ 2024-02-23T15:23:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-ok-chmp-a-terapia-cart-carvykti-nel-mieloma-multiplo/ 2024-02-26T09:53:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-svela-il-suo-piano-per-le-malattie-rare/ 2024-02-26T10:33:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/carenze-di-farmaci-e-dispositivi-medici-in-un-report-ocse-i-passaggi-per-rafforzare-le-catene-di-approvvigionamento-nella-fase-post-pandemica/ 2024-02-26T11:06:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/neuraxpharm-lancia-in-europa-briumvi-rms/ 2024-02-26T13:54:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-accordo-miliardario-con-neomorph-per-i-degradatori-di-colla-molecolare/ 2024-02-27T09:21:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giornata-delle-malattie-rare-limpegno-di-kyowa-kirin/ 2024-02-28T11:21:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-limpegno-per-cambiare-il-futuro-dellobesita/ 2024-02-27T10:57:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-breakthrough-therapy-da-fda-per-candidato-contro-nsclc/ 2024-02-27T13:18:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pnrr-arriva-un-nuovo-direttore-generale-per-il-ministero-della-salute-ad-agenas-un-ruolo-piu-forte-su-sanita-digitale-e-fascicolo-sanitario/ 2024-02-27T13:28:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/polifarma-torna-sul-mercato-con-la-linea-cardio-bracci-obiettivo-e-andare-verso-linnovazione-e-la-personalizzazione/ 2024-02-28T08:51:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipsen-con-odevixibat-un-2024-allinsegna-delle-malattie-rare/ 2024-02-28T13:05:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bristol-myers-squibb-acquisisce-rayzebio-per-41-miliardi-di-dollari/ 2024-02-28T13:37:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-rare-cattani-farmindustria-quasi-180-farmaci-approvati-dallema-tra-2002-e-2023-e-oltre-1-800-in-sviluppo-nel-mondo-il-30-del-totale/ 2024-02-28T17:00:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viatris-350-milioni-di-dollari-per-due-candidati-di-idorsia/ 2024-02-29T14:28:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giornata-mondiale-delle-malattie-rare-sanofi-accende-i-riflettori-sulla-ricerca/ 2024-02-29T11:18:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosense-webster-jj-la-piattaforma-varipulse-ottiene-la-marchiatura-ce/ 2024-02-29T13:12:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-lancia-sul-mercato-italiano-iberogastadvance-farmaco-sop-a-base-di-sostanze-vegetali-contro-i-disturbi-gastrici/ 2024-02-29T15:56:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-la-venture-capital-abingworth-investe-nello-sviluppo-di-trodelvy/ 2024-03-01T10:14:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-entro-il-2030-otto-blockbuster-oncologici/ 2024-03-01T11:30:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-53-mld-di-fatturato-2023-92-il-presidente-laureau-in-italia-16-mln-di-pazienti-curati-coi-nostri-farmaci/ 2024-03-01T17:12:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-italia-alessandra-brescianini-nuova-medical-director/ 2024-03-05T10:29:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fidia-farmaceutici-due-operazioni-commerciali-per-rafforzare-la-presenza-in-oftalmologia/ 2024-03-05T10:52:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ge-healthcare-un-podcast-per-sensibilizzare-sullalzheimer/ 2024-03-05T11:31:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-nasce-lalleanza-per-uninfanzia-libera-dallrsv/ 2024-03-05T15:08:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-italia-e-regione-piemonte-collaborazione-per-migliorare-la-presa-in-carico-dei-pazienti-oncologici/ 2024-03-05T14:44:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/al-via-la-13-edizione-dei-bandi-gilead-a-sostegno-della-ricerca-e-del-non-profit-italiano/ 2024-03-05T16:19:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scompare-paolo-chiesi-presidente-onorario-del-gruppo-farmaceutico/ 2024-03-06T09:18:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/beigene-nomina-pilar-de-la-rocha-nuova-head-of-europe-global-clinical-operations/ 2024-03-06T09:45:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-un-manifesto-per-affrontare-la-nuova-normalita/ 2024-03-06T11:27:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alexion-astrazeneca-rare-disease-aifa-approva-rimborsabilita-selumetinib/ 2024-03-06T13:43:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-fatturato-2023-a-43-mld-di-euro-53-nel-futuro-dellazienda-fiorentina-il-consolidamento-in-usa-e-lai/ 2024-03-07T08:46:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/laboratoires-pierre-fabre-acquista-da-kinnate-biopharma-i-diritti-di-exarafenib-inibitore-sperimentale-di-pan-raf/ 2024-03-07T09:41:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-nuovi-dati-sui-biomarcatori-sostengono-lefficacia-di-nusinersen-nella-sma/ 2024-03-07T10:15:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-investira-650-milioni-di-sterline-nel-regno-unito/ 2024-03-07T11:22:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dispositivi-medici-crollano-del-30-gli-investimenti-ma-tiene-lexport-35-pesano-effetto-payback-e-assenza-di-politica-attrattiva-barni-cdm-serve-nuova-governance-del-settore/ 2024-03-07T15:28:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/distribuzione-dei-farmaci-entro-il-30-marzo-lista-prodotti-trasferiti-dalla-diretta-o-per-conto-alla-convenzionata-gemmato-rivoluzione-straordinaria-nella-sua-semplicita/ 2024-03-08T09:57:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-nuovi-dati-su-remdesivir-da-tre-studi-real-world-sul-long-covid/ 2024-03-08T10:22:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/logistica-ups-healthcare-investe-ancora-in-italia/ 2024-03-08T10:50:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-acquisisce-ambrx-biopharma-per-2-miliardi-di-dollari/ 2024-03-11T08:48:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-ok-fda-a-wegoy-nel-settore-cardiovascolare/ 2024-03-11T14:42:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-da-aifa-rimborsabilita-per-dapagliflozin-nello-scompenso-cardiaco-cronico/ 2024-03-11T11:11:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-accordo-con-biotech-britannica-per-candidati-contro-la-schizofrenia/ 2024-03-12T09:35:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-amlitelimab-successore-di-dupixent-nella-dermatite-atopica/ 2024-03-12T10:20:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-da-aifa-rimborsabilita-per-durvalumab-nellepatocarcinoma-e-nel-tumore-delle-vie-biliari/ 2024-03-12T13:37:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-al-croi-presentati-gli-aggiornamenti-sulla-pipeline-hiv/ 2024-03-12T15:00:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ce-approva-il-vaccino-prevenar-20-s-pneumoniae/ 2024-03-13T09:42:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-lo-studio-daybreak-conferma-efficacia-e-sicurezza-di-ozanimod-nelle-forme-recidivanti-di-sm/ 2024-03-13T10:39:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-scommette-su-guselkumab-nella-colite-ulcerosa/ 2024-03-13T13:31:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-acquisisce-ifm-due-specializzata-in-immunoterapie/ 2024-03-14T09:40:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/galderma-ipo-da-26-miliardi-di-dollari-in-europa/ 2024-03-14T10:15:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-stada-un-2023-con-vendite-e-crescita-degli-utili-a-doppia-cifra/ 2024-03-14T10:48:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-buoni-risultati-per-candidato-contro-la-psoriasi-a-placche/ 2024-03-14T11:20:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/negli-usa-accordo-amazon-eli-lilly-per-acquisto-e-distribuzione-anti-diabete-obesita-ed-emicrania/ 2024-03-14T12:45:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-la-corte-ue-bacchetta-lema-deve-vigilare-su-conflitto-interesse-dei-suoi-esperti-e-annulla-decisione-del-chmp-su-no-a-un-farmaco/ 2024-03-14T14:06:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-arriva-in-italia-alirocumab-mensile-per-lipercolesterolemia/ 2024-03-14T13:25:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/angelini-pharma-e-sk-biopharmaceuticals-100-mila-pazienti-con-epilessia-in-tutto-il-mondo-trattati-con-cenobamato/ 2024-03-14T13:47:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-un-miliardo-di-dollari-per-amolyt-pharma-specializzata-in-malattie-rare/ 2024-03-15T09:14:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lunione-europea-della-salute-avanza-con-leu-health-data-space-i-pazienti-potranno-accedere-elettronicamente-ai-propri-dati-sanitari-personali-nei-diversi-sistemi-europei/ 2024-03-15T09:37:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-fda-approva-primo-farmaco-contro-la-mash/ 2024-03-15T10:27:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-aifa-estende-rimborsabilita-orkambi-ai-pazienti-pediatrici-con-fibrosi-cistica/ 2024-03-19T09:10:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-da-aifa-ok-a-rimborsabilita-tezepelumab-nellasma-grave-non-controllato/ 2024-03-19T09:12:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-una-road-map-per-migliorare-assistenza-e-cure-nelle-cardiomiopatie-in-italia/ 2024-03-19T10:17:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trial-clinici-fiaso-farmindustria-chiedono-tempi-piu-rapidi-per-lapprovazione-degli-studi-in-italia/ 2024-03-19T10:59:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-completa-lacquisizione-di-karuna-therapeutics-per-14-miliardi-di-dollari/ 2024-03-19T13:22:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-chiesi-firmato-il-contratto-integrativo-per-litalia-al-centro-la-persona/ 2024-03-19T16:26:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/legislazione-farmaceutica-dellue-arrivano-le-proposte-dei-deputati-europei-sulla-riforma/ 2024-03-19T17:01:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dario-guido-nominato-vice-president-of-health-medical-equipment-division-di-samsung-electronics-italia/ 2024-03-20T09:09:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anche-astrazeneca-scommette-sui-radiofarmaci-e-acquisisce-fusion-pharmaceuticals-per-24-miliardi-di-dollari/ 2024-03-20T09:48:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-arriva-in-italia-la-combo-foslevodopa-foscarbidopa-in-infusione-sottocutanea-per-parkinson-in-fase-avanzata/ 2024-03-20T10:26:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-nel-2023-presentate-allepo-ufficio-europeo-dei-brevetti-607-domande/ 2024-03-20T11:15:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-italia-giochiamo-danticipo-campagna-di-sensibilizzazione-sul-cancro-del-colon-retto-fa-tappa-a-roma/ 2024-03-20T13:15:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-pembrolizumab-piu-chemioradioterapia-migliora-la-sopravvivenza-globale-nelle-pazienti-con-nuova-diagnosi-di-tumore-della-cervice-uterina/ 2024-03-20T13:51:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-vince-il-premio-volontariwork/ 2024-03-21T09:31:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zambon-disponibile-in-italia-formulazione-orodispersibile-di-riluzolo-sla/ 2024-03-21T11:08:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-da-aifa-rimborsabilita-per-darolutamide-nel-tumore-alla-prostata-ormonosensibile-metastatico/ 2024-03-21T11:06:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-accordo-da-12-mld-di-dollari-con-roche-per-lacquisizione-di-un-sito-produttivo-di-farmaci-biologici/ 2024-03-21T11:43:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-innovative-medicine-premiati-a-roma-i-vincitori-del-contest-healthbot/ 2024-03-21T15:34:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-ecco-il-nuovo-cda/ 2024-03-21T16:13:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-ce-approva-abecma-terapia-cart-per-il-mieloma-multiplo-recidivato-e-refrattario/ 2024-03-22T11:46:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/colle-molecolari-la-nuova-frontiera-della-ricerca-farmaceutica/ 2024-03-22T10:31:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sobi-thebigb-uno-spettacolo-a-cielo-aperto-per-parlare-del-linfoma-a-grandi-cellule-b/ 2024-03-22T11:02:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-italia-tra-le-best-workplaces-2024/ 2024-03-22T12:05:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-da-aifa-ok-a-ibrutinib-e-venetoclax-nella-cll-precedentemente-non-trattata/ 2024-03-22T13:45:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-infezioni-chmp-dellema-raccomanda-immissione-in-commercio-di-emblaveo/ 2024-03-25T10:03:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-alla-prostata-stratificare-il-rischio-e-migliorare-lappropriatezza-della-diagnosi-precoce-con-test-di-laboratorio-innovativi-e-risonanza-magnetica-uno-studio-dellistituto-cl/ 2024-03-25T10:24:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-nsclc-avanzato-con-mutazione-di-egfr-con-osimertinib-e-chemioterapia-andamento-favorevole-della-sopravvivenza-globale/ 2024-03-25T11:12:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-da-chmp-parere-positivo-a-fabhalta-nella-epn/ 2024-03-25T13:49:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-esperion-therapeutics-parere-positivo-chmp-a-estensioni-indicazioni-acido-bempedoico-e-associazione-fissa-di-acido-bempedoico-ezetimibe-nella-riduzione-degli-eventi-cardiovascolari/ 2024-03-25T14:56:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-continua-lo-shopping-acquisita-cardior-pharmaceuticals/ 2024-03-26T09:28:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-per-la-presidenza-e-robert-nistico-il-nome-che-schillaci-proporra-alle-regioni-uno-psichiatra-verso-il-vertice-dellagenzia/ 2024-03-26T09:50:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-ce-approva-idecel-nel-mieloma-multiplo-recidivato-e-refrattario-triplo-esposto/ 2024-03-26T10:44:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-italia-nasce-il-clinical-development-center/ 2024-03-26T15:03:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-punta-sulle-malattie-infiammatorie-e-acquisisce-landos-biopharma/ 2024-03-26T14:38:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-fda-approva-winrevair-primo-farmaco-che-agisce-sulle-cause-dellipertensione-arteriosa-polmonare/ 2024-03-27T09:01:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-il-vaccino-covid19-next-gen-si-dimostra-promettente/ 2024-03-27T09:49:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/italfarmaco-fda-approva-primo-farmaco-orale-non-steroideo-per-la-distrofia-muscolare-di-duchenne/ 2024-03-27T10:51:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-ovarico-lappello-dellovarian-cancer-commitment/ 2024-03-27T11:29:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/donne-e-uomini-in-farmacia-ecco-la-classifica-per-genere-dei-medicinali-piu-venduti/ 2024-03-28T09:26:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-aifa-a-rimborsabilita-acalabrutinib-nella-nuova-formulazione-in-compresse-llc/ 2024-03-28T15:51:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/advanz-pharma-e-allecra-ce-concede-aic-a-exblifep-nuova-combinazione-antibiotica-per-il-trattamento-delle-infezioni-gravi/ 2024-03-28T11:19:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-nuova-sede-al-centro-di-roma/ 2024-03-28T13:26:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otsuka-e-lundbeck-ce-approva-aripiprazolo-960-mg-a-lunga-durata-di-azione-con-somministrazione-bimestrale-schizofrenia/ 2024-03-28T13:47:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/walgreens-boots-alliance-positivo-il-secondo-trimestre-dellanno-fiscale-2024/ 2024-03-28T14:22:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-punta-su-un-farmaco-antitumorale-di-xilio-therapeutics/ 2024-03-29T09:10:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-nuovo-stabilimento-in-irlanda/ 2024-03-29T09:32:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/humanizing-health-awards-teva-italia-premia-gli-enti-no-profit-impegnati-nellumanizzazione-delle-cure/ 2024-03-29T09:54:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-ce-approva-pembrolizumab-prima-e-dopo-chirurgia-del-tumore-al-polmone-in-stadio-precoce/ 2024-03-29T10:48:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-arriva-il-nuovo-ceo/ 2024-04-03T09:43:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/solventum-completato-lo-spinoff-da-3m/ 2024-04-03T10:00:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipsen-entra-nel-mondo-degli-adc-grazie-a-un-accordo-con-sutro-biopharma/ 2024-04-03T10:30:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-nasce-vax-corner-portale-di-informazione-medico-scientifica-sulle-vaccinazioni-riservato-agli-operatori-sanitari/ 2024-04-03T12:11:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kyowa-kirin-un-impegno-quotidiano-per-ambienti-di-lavoro-piu-inclusivi/ 2024-04-03T12:40:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-e-legend-novartis-entra-nellaccordo-per-la-produzione-commerciale-di-carvykti/ 2024-04-03T16:05:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-e-fondazione-roche-premiati-i-vincitori-dei-bandi-2023/ 2024-04-03T15:44:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuovo-takeover-nel-campo-degli-adc-genmab-acquisisce-profoundbio-per-18-mld-di-dollari/ 2024-04-04T09:02:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-entra-nel-network-europeo-eit-health/ 2024-04-04T09:22:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-fda-a-voydeya-nella-epn/ 2024-04-04T10:19:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-robert-nistico-e-il-nuovo-presidente-arriva-lintesa-con-le-regioni/ 2024-04-04T12:14:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giornata-mondiale-della-salute-loms-lancia-sarah/ 2024-04-05T09:09:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amylyx-ritira-dal-mercato-usa-farmaco-per-la-sla/ 2024-04-05T15:23:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/touchlight-e-universita-di-liverpool-insieme-per-un-vaccino-contro-il-nsclc/ 2024-04-05T13:10:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/confindustria-dispositivi-medici-rinnovati-i-vertici-delle-associazioni-di-categoria/ 2024-04-05T13:31:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gavi-al-via-la-piu-grande-campagna-di-distribuzione-globale-di-test-diagnostici-rapidi-per-la-lotta-contro-il-colera/ 2024-04-05T14:13:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-acquisisce-shockwave-medical-per-131-miliardi-di-dollari-e-rafforza-il-portfolio-cardiovascolare/ 2024-04-08T15:36:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anche-merck-kgaa-punta-sugli-adc-accordo-con-biotech-caris-per-uso-ai-nella-progettazione/ 2024-04-08T08:18:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sindromi-mielodisplastiche-ce-estende-approvazione-di-luspatercept-di-bms-ai-pazienti-adulti-con-anemia-trasfusione-dipendente/ 2024-04-08T09:10:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fujifilm-italia-raddoppia-nasce-fujifilm-italia-healthcare/ 2024-04-08T14:08:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-generici-in-italia-spagna-e-giappone-vince-ancora-la-brand-loyalty/ 2024-04-09T08:44:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-wegovy-puo-alleviare-i-sintomi-dellinsufficienza-cardiaca-negli-obesi/ 2024-04-09T09:27:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/limportanza-delloutsourcing-per-i-farmaci-anticorpali/ 2024-04-09T13:22:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epatiti-virali-ogni-giorno-nel-mondo-muoiono-3-500-persone-a-causa-di-infezioni-da-hbv-e-hcv-loms-lancia-lallarme/ 2024-04-09T13:54:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-e-google-cloud-insieme-per-una-piattaforma-ai-destinata-ai-radiologi/ 2024-04-10T15:38:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dopo-il-ritiro-del-farmaco-di-amylyx-via-libera-fda-a-sperimentazione-nuovo-candidato-per-la-sla/ 2024-04-10T09:50:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-aifa-a-glofitamab-nel-dlbcl-recidivante-o-refrattario/ 2024-04-10T13:05:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-dagli-ospedali-alle-farmacie-intervista-a-gemmato-si-comincia-con-gli-antidiabetici-orali/ 2024-04-10T14:12:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-italia-con-la-nazionale-di-rugby-per-mens-pro-campagna-di-informazione-sul-tumore-della-prostata-metastatico/ 2024-04-10T15:17:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-parlamento-europeo-dice-si-alla-riforma-del-sistema-farmaceutico-nellue/ 2024-04-11T13:55:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-acquisisce-alpine-immune-sciences-per-49-miliardi-di-dollari-e-si-rafforza-in-nefrologia/ 2024-04-11T09:08:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-si-illumina-di-verde-e-di-blu-per-la-prima-notte-mondiale-del-parkinson/ 2024-04-11T10:31:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-nella-cse-entra-bruna-vinci-al-posto-di-vincenzo-lozupone/ 2024-04-11T12:12:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-dati-positivi-da-studi-di-fase-iii-per-v116-primo-vaccino-pneumococcico-coniugato-21valente-disegnato-per-gli-adulti/ 2024-04-11T13:22:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-unopportunita-a-rischio-in-italia-e-in-europa-le-aziende-lanciano-lalert-per-la-sostenibilita-del-comparto/ 2024-04-11T14:14:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-gruppo-servier-lancia-affetti-desiderati-campagna-di-sensibilizzazione-sulladerenza-alle-terapie-cardiometaboliche/ 2024-04-12T09:49:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-a-berlino-un-impianto-per-la-produzione-su-scala-globale-di-oligonucleotidi/ 2024-04-12T10:13:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/asma-bronchiale-ruolo-di-eosinofili-infiammatori-e-trattamento-con-mepolizumab/ 2024-04-12T14:17:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-landazabal-gsk-usare-tecnologia-per-chiamata-attiva-aumenta-copertura/ 2024-04-12T16:25:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/31021/ 2024-04-13T15:56:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-fda-estende-benralizumab-ai-pazienti-6-11-anni-con-asma-grave-e-fenotipo-eosinofilo/ 2024-04-15T08:29:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-si-a-malattia-minima-residua-come-nuovo-endpoint-negli-studi-sui-trattamento-per-il-mieloma/ 2024-04-15T15:00:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-nessun-rischio-ideazioni-suicidarie-con-i-farmaci-glp1/ 2024-04-15T10:25:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tecnologie-crispr-un-mercato-da-21-miliardi-di-dollari/ 2024-04-15T12:42:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-eli-lilly-il-premio-leonardo-international/ 2024-04-15T14:07:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sergio-liberatore-e-il-nuovo-ceo-di-homnya/ 2024-04-15T14:40:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-lancia-un-proprio-fondo-di-venture-capital/ 2024-04-16T16:12:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viatris-la-nuova-cco-e-corinne-le-goff/ 2024-04-16T08:53:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fujifilm-punta-sulla-cdmo-e-investe-12-miliardi-di-dollari/ 2024-04-16T09:42:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-a-luglio-riunione-del-novel-medicines-platform-delloms-europea/ 2024-04-16T13:21:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kyowa-kirin-in-studio-real-life-mogamulizumab-efficace-nel-linfoma-cutaneo-a-cellule-t/ 2024-04-16T15:15:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-grandi-performance-per-jardiance-e-ofev-nel-2023/ 2024-04-17T08:49:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-the-lancet-neurology-pubblica-i-risultati-positivi-dello-studio-elevate-su-atogepant-emicrania/ 2024-04-17T09:15:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-aquaflor-arriva-il-profumo-dei-ricordi/ 2024-04-17T12:20:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/homnya-annuncia-acquisizione-editoriale-giornalidea/ 2024-04-17T12:33:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-via-libera-al-regolamento-che-disciplina-funzionamento-commissione-scientificoeconomica/ 2024-04-17T16:47:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/beckman-coulter-presenta-i-nuovi-dosaggi-per-lepatite-marcati-ce-di-dxi-9000-analyzer/ 2024-04-17T16:58:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-igm-collaborazione-esclusiva-su-immunologia-e-infiammazione/ 2024-04-18T08:36:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-tirzepatide-mostra-benefici-nel-trattamento-delle-osas-nuova-strada-per-i-glp-1/ 2024-04-18T09:25:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/comincia-bene-lanno-di-jj-crescono-gli-utili-nel-q1-2024/ 2024-04-18T10:20:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/foglietti-illustrativi-arriva-il-position-paper-dellindustria-farmaceutica-europea/ 2024-04-18T10:31:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cerevel-abbvie-risultati-positivi-per-tavapadon-nella-malattia-di-parkinson/ 2024-04-21T15:56:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ocrelizumab-sottocute-sopprime-recidive-cliniche-e-lesioni-cerebrali-nei-pazienti-con-forme-progressive-e-recidivanti-di-sm/ 2024-04-19T09:40:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-donne-ancora-sottorappresentate-negli-studi-clinici-lefficacia-della-terapia-bftaf/ 2024-04-19T12:37:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/google-cloud-ancora-una-partnership-per-lai-nelle-lifescience/ 2024-04-19T13:43:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/virus-respiratorio-sinciziale-strategie-di-prevenzione-per-ridurre-decessi-e-spese-per-il-ssn/ 2024-04-19T15:09:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-la-battaglia-per-i-biosimilari-accordo-alvotechteva-per-laccesso-al-biosimilare-di-humira-abbvie/ 2024-04-22T08:45:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-chiesi-il-fatturato-2023-supera-i-3-mld-di-euro-premiato-il-nuovo-modello-operativo/ 2024-04-22T09:43:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-cda-approva-regolamento-cse-con-norme-su-organizzazione-e-funzionamento/ 2024-04-22T10:01:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/efpia-rafforzare-la-competitivita-delle-lifescience-in-europa/ 2024-04-22T13:58:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-la-commissione-europea-approva-lantibiotico-emblaveo/ 2024-04-23T08:46:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipsen-accordo-con-biotech-usa-per-farmaci-mirati-allrna-nella-patologie-neurologiche-rare/ 2024-04-23T14:54:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-astellas-e-sumitomo-joint-venture-per-accelerare-la-ricerca-in-giappone/ 2024-04-23T09:54:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-durvalumab-piu-chemioterapia-raddoppia-tasso-di-sopravvivenza-globale-a-tre-anni-nel-tumore-delle-vie-biliari/ 2024-04-23T10:30:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bristol-myers-squibb-accordo-con-cellares-per-rafforzare-la-produzione-delle-terapie-cart/ 2024-04-23T14:51:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipereosinofilia-complessa-primo-documento-per-la-gestione-della-patologia/ 2024-04-23T14:48:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-frexalimab-altamente-efficace-a-48-settimane-nei-pazienti-con-sclerosi-multipla/ 2024-04-23T14:10:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/angelini-pharma-una-consensus-per-fare-il-punto-sullepilessia-focale-in-italia/ 2024-04-24T08:43:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/litaliana-doc-acquisisce-il-brand-muscoril-da-sanofi/ 2024-04-24T09:14:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-ce-estende-indicazione-di-cilta-cel-al-rrmm/ 2024-04-24T10:42:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-q1-brillante-giovanni-caforio-nuovo-presidente/ 2024-04-24T10:49:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-q1-allinsegna-della-crescita-a-due-cifre/ 2024-04-26T09:41:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-nice-raccomanda-combo-dabrafenib-trametinib-nel-trattamento-del-glioma/ 2024-04-26T10:07:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-nuovo-centro-di-ricerca-a-darmstadt/ 2024-04-26T10:36:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-punta-sul-farmaco-contro-la-depressione-post-partum/ 2024-04-26T13:08:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-rilzabrutinib-raggiunge-lendpoint-primario-in-studio-fase-iii-sulla-trombocitopenia-immune/ 2024-04-29T09:36:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-volano-gli-utili-nel-q1-2024/ 2024-04-29T15:37:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-la-commissione-europea-autorizza-biosimilare-di-ustekinumab/ 2024-04-29T12:30:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ok-fda-a-terapia-genica-per-lemofilia-b/ 2024-04-29T13:20:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/monitoraggio-spesa-farmaceutica-report-aifa-nei-primi-11-mesi-del-2023-supera-i-20-miliardi-di-euro/ 2024-04-29T13:44:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rosati-gsk-momelotinib-disponibile-in-uso-compassionevole-ma-gsk-ha-gia-sottoposto-ad-aifa-richiesta-di-approvazione/ 2024-04-30T14:43:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-ono-pharmaceutical-acquisisce-la-biotech-deciphera-per-24-miliardi-di-dollari/ 2024-04-30T12:27:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-ed-evotec-obiettivo-cardiologia-di-precisione/ 2024-04-30T09:31:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-da-uno-studio-di-confronto-risultati-positivi-per-upadacitinib/ 2024-04-30T12:33:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mercato-dei-farmaci-in-farmacia-in-un-anno-venduti-18-miliardi-di-confezioni/ 2024-05-02T09:18:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zambon-sceglie-giovanni-magnaghi-come-amministratore-delegato/ 2024-05-03T08:03:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-nirsevimab-riduce-dell82-le-ospedalizzazioni-per-rsv-nei-neonati/ 2024-05-03T08:24:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-alza-le-previsioni-del-2024-grazie-ai-vaccini-e-ai-farmaci-contro-lhiv/ 2024-05-03T08:48:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-trastuzumab-deruxtecan-migliora-la-sopravvivenza-libera-da-progressione-nel-carcinoma-mammario-metastatico-hr-positivo/ 2024-05-03T08:50:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-nuovo-shopping-nei-radiofarmaci-acquisita-mariana-oncology/ 2024-05-03T09:29:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-q1-conferma-la-ripresa-su-base-trimestrale/ 2024-05-03T12:57:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/csl-seqirus-nuovi-dati-real-world-dimostrano-efficacia-vaccino-antinfluenzale-quadrivalente-su-coltura-cellulare-durante-tre-stagioni-influenzali-consecutive/ 2024-05-03T14:25:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-roche-antonio-modola-e-il-nuovo-segretario-generale/ 2024-05-06T09:08:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-un-super-manager-per-guidare-strategia-e-innovazione/ 2024-05-07T08:56:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-aumentano-del-22-i-ricavi-netti-del-q1/ 2024-05-07T09:45:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-e-gossamer-bio-collaborazione-per-lo-sviluppo-e-la-commercializzazione-di-seralutinib-nellipertensione-arteriosa/ 2024-05-07T10:10:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-aumenta-la-partecipazione-in-cellectis-per-sviluppare-terapie-geniche/ 2024-05-07T12:32:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rs-chi-ha-speso-di-piu-nel-2023/ 2024-05-07T14:56:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/adolescenti-device-digitali-e-disturbi-del-sonno/ 2024-05-07T14:05:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ritira-il-suo-vaccino-anti-covid-in-tutto-il-mondo/ 2024-05-08T12:24:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-nel-q1-lutile-netto-supera-i-2-miliardi-di-dollari/ 2024-05-08T09:30:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-da-ofatumumab-benefici-sostanziali-nei-pazienti-con-sclerosi-multipla-recidivante-di-recente-diagnosi-e-non-ancora-in-trattamento/ 2024-05-08T10:10:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/becton-dickinson-un-incontro-a-roma-per-gestire-il-percorso-diagnostico-delle-pid/ 2024-05-08T13:14:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/beckman-coulter-presenta-lanalizzatore-di-chimica-clinica-dxc-500-au/ 2024-05-09T13:17:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-iniettabili-mercato-in-crescita/ 2024-05-09T08:59:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-il-10-giugno-la-fda-decide-su-donanemab-alzheimer/ 2024-05-09T09:49:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-tavolo-tecnico-con-farmindustria-per-semplificare-le-procedure-e-dimezzare-i-tempi-per-laccesso-dei-farmaci/ 2024-05-09T12:20:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-accordo-con-metaphore-biotechnologies-per-due-farmaci-per-lobesita/ 2024-05-10T08:50:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-pharma-ecco-quanto-hanno-guadagnato-i-ceo-nel-2023/ 2024-05-10T10:50:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-al-via-la-campagna-non-sono-tutti-uguali-tumori-al-seno-e-percorsi-di-vita/ 2024-05-10T13:03:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-al-via-il-progetto-metadinamiche-esperienza-immersiva-per-le-cure-integrate-nel-tumore-al-seno-metastatico/ 2024-05-13T10:51:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-accordo-di-licenza-con-novavax-per-i-vaccini-anti-covid-e-combo-influenza-covid/ 2024-05-13T12:32:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ok-nice-a-vyndaqel-per-la-cura-della-attrcm/ 2024-05-13T12:48:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-fda-ritarda-la-decisione-sul-vaccino-anti-rsv-di-moderna/ 2024-05-13T13:25:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-rapporto-horizon-scanning-aifa-104-nuove-terapie-in-arrivo-nel-2024-soprattutto-in-oncologia-oncoematologia-e-sistema-nervoso/ 2024-05-13T15:30:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-chiesi-e-karolinska-institutet-insieme-per-affrontare-le-sfide-sanitarie-piu-urgenti/ 2024-05-14T13:21:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-accordo-con-ac-immune-per-vaccino-e-immunoterapie-contro-lalzheimer/ 2024-05-14T13:50:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-1-miliardo-di-dollari-a-fulcrum-per-candidato-contro-la-distrofia-muscolare-facioscapoloomerale/ 2024-05-14T10:10:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-semaglutide-riduce-il-rischio-cardiovascolare/ 2024-05-14T10:36:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-premio-internazionale-fair-play-menarini-scalda-i-motori-ecco-le-date-delledizione-2024/ 2024-05-14T10:57:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/incontro-aifa-egualia-nistico-al-lavoro-per-assicurare-che-tutti-i-farmaci-essenziali-siano-disponibili-per-i-pazienti-italiani/ 2024-05-14T13:55:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pierre-fabre-ok-chmp-a-vibegron-nella-sindrome-della-vescica-iperattiva/ 2024-05-14T13:03:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-disponibile-il-primo-biosimilare-a-base-di-natalizumab-per-la-sclerosi-multipla/ 2024-05-15T08:46:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-prende-forma-la-ristrutturazione-voluta-dal-ceo-bill-anderson/ 2024-05-15T15:18:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/argenx-italia-fabrizio-celia-nuovo-general-manager/ 2024-05-15T10:13:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alexion-astrazeneca-rare-disease-nasce-la-campagna-siamo-infinite-sfumature-oltre-i-segni-della-neurofibromatosi/ 2024-05-15T10:59:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-oms-prequalifica-vaccino-tak003-contro-la-dengue/ 2024-05-15T12:49:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-roche-con-aiot-per-il-progetto-respiriamo-insieme/ 2024-05-16T09:30:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eisai-avvia-la-richiesta-di-licenza-biologica-alla-fda-per-leqembi-iniettabile/ 2024-05-16T10:28:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-un-miliardo-di-euro-per-rafforzare-la-bioproduzione-in-francia/ 2024-05-16T12:27:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/confindustria-dm-e-aisdet-accordo-per-lo-sviluppo-della-sanita/ 2024-05-16T14:25:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-un-incontro-a-roma-sulloncologia-di-precisione/ 2024-05-17T08:34:47+00:00 monthly 0.2